呼吸器系薬物送達技術市場レポート:2022-2032
Respiratory Drug Delivery Technologies Market Report 2022-2032
レポート詳細
呼吸器系薬物送達技術市場レポート 2022-2032 :本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益... もっと見る
※上記価格は部署ライセンス(Departmental licence)価格です。 その他の価格についてはデータリソースまでお問合せください。 日本語のページは自動翻訳を利用し作成しています。 実際のレポートは英文のみでご納品いたします。
サマリー
レポート詳細
呼吸器系薬物送達技術市場レポート 2022-2032:本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なものとなるでしょう。また、異業種への進出や新地域での既存事業の拡大を目指す企業にとっても有用なレポートです。
呼吸器系疾患の増加、技術の進歩、COVID-19パンデミックの発生が市場成長を促進する
世界の呼吸器系薬物送達技術市場を推進する主な要因としては、呼吸器系疾患の有病率と発生率の増加、呼吸器系薬物送達の技術的進歩、Covid-19パンデミックの発生などが挙げられます。さらに、呼吸器系薬物送達システムにおけるナノ粒子と高分子キャリアの使用は、市場全体を推進すると予想されます。この分野のいくつかの傾向は、吸入装置や製剤の最近の進歩によって示されています。高用量の乾燥粉末製剤の代替品は、ネブライザーによる処方でますます人気が高まっており、新しい高用量(>100 mg)DPI(乾燥粉末吸入器)バリアントの開発によって支えられることになるでしょう。使い捨ての乾燥粉末吸入器は、感染症を含むさまざまな呼吸器系疾患の治療に役立つ可能性があります。
ネブライザー、特にスマートカードと電子制御ユニットを使用し、肺への沈着と総投与量を正確に指示できるソフトウェア支援システムは、新しいがん治療において重要な役割を果たすとともに、吸入治療の臨床試験の信頼性を向上させるだろう。また、将来のエアロゾルの製剤には、再利用された薬剤の割合が多くなると予想されます。
DPI(Dry Powder Inhalers)用の肺ドラッグデリバリー製剤におけるナノ粒子の使用は、依然としてホットトピックである。同薬剤のナノ粒子は、微粉化した硫酸サルブタモールと比較して、ヒトでは口腔咽頭部への影響が著しく少なく、末梢沈着量が多いことが判明し、サイズが小さいため、局所バイオアベイラビリティが高く、持続的に利用できることが示唆されました。
呼吸器系薬物送達の障害
呼吸器系は、吸入された薬物粒子を肺に入れないようにし、いったん定着した粒子を排除または不活性化するための自己防衛方法を進化させてきたため、肺への薬物投与は比較的困難である。機械的、薬理学的、免疫学的な障壁に加え、コンプライアンスや吸入技術などの行動的な障壁が肺への薬剤投与にマイナスの影響を及ぼします。これらの障壁の影響を緩和する戦略には、肺に効率的に薬剤を送達する吸入器デバイスおよび組成物の使用、適切な吸入技術、および患者教育の強化が含まれる。呼吸器系薬物送達デバイスが適切に使用されれば、肺ルートは大きな機会を提供し、しばしば満たされていない臨床要件を満たすことができます。
マーケットリサーチレポートを購入する前に、どのような質問をすべきでしょうか?
- 呼吸器系薬物送達技術市場はどのように進化しているのか?
- 呼吸器系薬物送達技術市場の推進要因と抑制要因は何か?
- 呼吸器系薬物送達技術の各サブマーケット区分は予測期間中にどのように成長し、2032年にこれらのサブマーケットが占める売上はどの程度になるのか?
- 2022年から2032年にかけて、呼吸器系薬物送達技術の各サブマーケットの市場シェアはどのように推移するのか?
- 2022年から2032年にかけて、市場全体の主なドライバーは何になるのでしょうか?
- 呼吸器系薬物送達技術の主要市場はマクロ経済のダイナミクスに概ね追随するのか、それとも個々の国内市場が他を凌駕するのか?
- 2032年までに各国市場のシェアはどのように変化し、どの地域が2032年の市場をリードするのでしょうか?
- 主要プレイヤーは誰か、また予測期間中の見通しは?
- これらの主要企業の呼吸器系薬物送達技術プロジェクトはどのようなものですか?
- 2022年から2032年の間に、業界はどのように進化していくのか?現在および今後10年間に行われる呼吸器系薬物送達技術プロジェクトにはどのような意味があるのでしょうか?
- 呼吸器系薬物送達技術市場をさらに拡大するために、製品の商業化の必要性は高いか?
- 呼吸器系薬物送達技術市場はどこへ向かっているのか?そして、どうすれば市場の最前線に立つことができるのか?
- 新製品やサービスラインに対する最適な投資オプションは何か?
- 企業を新たな成長軌道に乗せるための重要な展望と? C-suiteは?
このことが呼吸器系薬物送達技術市場に現在、そして今後10年間にどのような影響を与えるかを知る必要があります。
- 587ページにわたる本レポートでは、456の表と454のグラフを独占的に提供します。
- このレポートでは、業界における主要な収益性の高い分野をハイライトしているため、今すぐターゲットを絞ることができます。
- 世界、地域、国別の売上高と成長率の詳細な分析が含まれています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。
このレポートは、呼吸器系薬物送達技術市場が今後10年間にどのように発展するか、またCOVID-19の景気後退と回復の変動に即して、今日あなたにお伝えします。この市場は、過去10年間のどの時点よりも今が重要なのです。
レポートでは、COVID-19のバリエーションや経済データなど、お客様の市場に特化した独自の情報をお届けしています。
2032年までの予測やその他の分析により、商業的な展望が見えてくる
- 2032年までの収益予測に加え、直近の実績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望や展開など、独自の分析もご覧いただけます。
- 定性的分析(市場力学、推進要因、機会、阻害要因、課題など)、コスト構造、呼吸器系薬物送達技術の価格上昇の影響、最近の開発状況をご覧いただけます。
本レポートでは、COVID-19が業界と貴社にどのような影響を与えるかについて、データ分析と貴重な洞察を掲載しています。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じています。
レポートの対象セグメント
製品別
- 製剤
- デバイス
タイプ別
- 乾燥粉体
- 懸濁液エアゾール
- 溶液エアゾール
製品別タイプ
- 定量噴霧式吸入器 (MDIS)
- ドライパウダー吸入器 (DPIS)
- ネブライザー・アクセサリー
ネブライザータイプ別
- ソフトミストネブライザー
- ジェットネブライザー
- 超音波ネブライザー
キャニスタータイプ別
- プレーンキャニスター
- コート付きキャニスター
用途別
- 気管支喘息
- 慢性閉塞性肺疾患
- 嚢胞性線維症
- その他
エンドユーザー別
- 在宅医療
- 病院・クリニック
- その他
世界市場全体とセグメントの収益予測に加え、5つの地域と21の主要国市場の収益予測も掲載しています。
北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- スペイン
- イギリス
- フランス
- イタリア
- その他の欧州
アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 南朝鮮
- その他のアジア太平洋地域
ラテンアメリカ
- ブラジル
- メキシコ
-その他のラテンアメリカ地域
MEA
- GCC
- 南アフリカ
-その他のMEA
呼吸器系薬物送達技術市場の2022年から2032年にかけての主要企業のプロファイルと、これらの企業のこのセグメントに焦点を当てた内容も含まれています。
主要企業
・ AptarGroup, Inc.
・ AstraZeneca plc.
・ Boehringer Ingelheim GmbH
・ Cipla Limited
・ Graham Field Health Products
・ GSK Corporation
・ Medisana GmbH.
・ Merck & Co., Inc.
・ Novartis AG
・ Omron Corporation
・ Philips Respironics
・ Recipharm Ab.
・ Sunovion Pharmaceuticals Inc.
・ Teva Pharmaceuticals
・ 3M Healthcare
呼吸器系薬物送達技術市場の世界全体の収益、金額で2022年から2032年まで、市場は2022年に595億1000万米ドルを超えると、我々の仕事は計算しています。2032年までの収益成長率も高いことが予測されます。本調査では、最も大きな可能性を秘めた企業を特定します。彼らの能力、進歩、商業的展望を知ることで、一歩先を行くことができます。
呼吸器系薬物送達技術市場、2022年から2032年までの市場レポートはどのように役立つのでしょうか?
580ページを超えるレポートでは、要約すると以下のような知識を得ることができます。
- 呼吸器系薬物送達技術市場の2032年までの収益予測、世界と地域レベルで予測した各タイプの企業規模-業界の展望を発見し、投資と収益の最も有利な場所を見つける。
- 5地域と21主要国市場の2032年までの収益予測 - 呼吸器系薬物送達技術市場の2022年から2032年までの北米、ヨーロッパ、アジア太平洋、LAMEAの市場予測をご覧いただけます。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの主要経済圏の市場も予測されています。
- 呼吸器系薬物送達技術市場に関与する主要企業15社の企業プロファイルを含む、既存企業および市場参入を目指す企業の展望(2022年~2032年)。
定量的・定性的な分析と独自の予測をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスを得ることができます。
他にはない情報
私たちの新しいレポートがあれば、知識の遅れを取り戻し、チャンスを逃す可能性が低くなります。私たちの研究が貴社の研究、分析、意思決定にどのように役立つかをご覧ください。Visiongainの研究は、呼吸器系薬物送達技術市場、2022年から2032年の市場の主要企業のための商業分析を必要とするすべての人のためのものです。データ、トレンド、予測を見つけることができます。
ページTOPに戻る
目次
目次
1.レポートの概要
1.1 呼吸器系薬物送達技術市場の紹介
1.2 本レポートを読むべき理由
1.3 本レポートが提供するもの
1.4 本分析レポートが回答する主な質問には以下が含まれます。
1.5 本レポートは誰のためのものなのか?
1.6 方法論
1.6.1 一次調査
1.6.2 セカンダリーリサーチ
1.6.3 市場評価・予測手法
1.7 よくある質問(FAQ)
1.8 関連するVisiongainのレポート
1.9 Visiongainについて
2 エグゼクティブサマリー
3 マーケットダイナミクス
3.1 呼吸器系薬物送達技術市場の促進要因
3.1.1 呼吸器系疾患の有病率・発症率の増加が市場を牽引
3.1.2 呼吸器系薬物送達の技術的進歩による市場拡大への期待
3.1.3 COVID-19のパンデミックの発生
3.1.4 呼吸器疾患医療啓発のための政府・NGOの支援拡大
3.1.5 スマート/デジタル吸入器の発売により、高度な薬物送達デバイスの採用が促進される
3.2 呼吸器系薬物送達技術市場の阻害要因
3.2.1 厳しい政府規制が市場成長の妨げになる見込み
3.2.2 ベンダー間の激しい競争が市場成長を抑制すると予想される
3.3 呼吸器官用薬物送達技術市場の機会
3.3.1 Metered Dose Inhaler(MDI)技術の動向は、近い将来、市場を促進すると予想される
3.3.2 市場プレイヤーによる合併、契約、買収は、市場で目撃された主要な傾向である
3.3.3 ドライパウダー・ドラックデリバリー製品の革新が呼吸器系薬剤の採用を促進
3.4 呼吸器官用薬物送達技術市場の課題
3.4.1 価格設定への圧力が大きな課題
3.4.2 呼吸器官用薬剤の送達設計に関連する課題
3.4.3 呼吸器官用薬剤のデリバリーに関する障壁
3.5 呼吸器官用薬物送達技術市場のSWOT分析
3.5.1 強み
3.5.1.1 効果的な薬物吸収と便利な自己投与へのニーズの高まりがR&D投資の重要性を高める
3.5.2 弱点
3.5.2.1 革新的な薬物送達技術の失敗による経済的損失が大きな問題になっている。
3.5.3 Opportunities
3.5.3.1 バイオ製薬企業間の提携の増加
3.5.4 Threats5.4 脅威:ドラッグデリバリーテクノロジー市場
3.5.4.1 呼吸器系薬剤のサプライチェーンの混乱が呼吸器系薬物送達市場の最大の脅威である
3.6 ポーターのファイブフォース分析。呼吸器官用薬物送達技術市場
3.6.1 サプライヤーのバーゲニングパワー。高い
3.6.2 新規参入の脅威。中程度
3.6.3 バイヤーの交渉力:中程度
3.6.4 競争相手との競合:高
3.6.5 代替品の脅威:中程度
3.7 PEST分析。呼吸器系薬物送達技術市場
3.7.1 呼吸器官用薬物送達技術市場に影響を与える政治的要因
3.7.2 呼吸器官用薬物送達技術市場に影響を与える経済的要因
3.7.3 呼吸器官用薬物送達技術市場に影響を与える社会的要因
3.7.4 呼吸器官用薬物送達技術市場に影響を与える技術的要因
4 世界の呼吸器系薬物送達技術市場
4.1 呼吸器系薬物送達技術の世界市場予測、2022-2032年
4.2 COVID-19のインパクトの概要
4.3 "V "字回復 -急減速 -急降下 -急回復
4.4 "U "字型回復 -初期に急速に減少し、その後徐々に減少 -底で徐々に減少 -最初はゆっくり回復 -後で速く回復
4.5 "W字回復 -急降下 -急回復 -ウイルスの復活 -再び急降下 -回復
4.6 "L "字型の回復 - 急激な減少 - その後、ゆっくりと成長
5 世界の呼吸器系薬物送達技術市場規模予測、製品別 2022-2032年
5.1 世界の呼吸器官用薬物送達製剤のセグメント。収益予測 2022-2032
5.1.1 効率的な製剤への要求の高まりが市場成長を後押しする
5.1.2 回復予測(V、U、W、L)
5.2 呼吸器官用薬物送達デバイスの世界セグメント。収益予測 2022-2032
5.2.1 呼吸器官用薬物送達デバイスは最大の収益セグメントを占める
5.2.2 回復予測(V、U、W、L)
6 呼吸器用薬物送達製剤市場予測、タイプ別 2022-2032年
6.1 乾燥粉末製剤セグメント市場予測、2022-2032年
6.1.1 ドライパウダーの吸入は従来の経口薬よりはるかに利便性が高い
6.1.2 回復のシナリオ(V、U、W、L)
6.2 懸濁液エアロゾルセグメント市場予測、2022-2032年
6.2.1 最も広く使用されている吸入薬は気管支拡張剤と副腎皮質ステロイド剤
6.2.2 回復シナリオ(V、U、W、L)
6.3 ソリューションエアロゾルセグメント市場予測、2022-2032年
6.3.1 喘息やその他の呼吸器疾患を管理するための高度な治療への需要の高まり
6.3.2 回復シナリオ (V, U, W, L)
7 呼吸器用薬物送達デバイス市場予測、タイプ別 2022-2032年
7.1 定量噴霧式吸入器(MDI) セグメントの市場予測、2022-2032年
7.1.1 定量噴霧式吸入器 (MDI)は薬の細かいミストを供給するために設計された自動化されたシステムである
7.1.2 リカバリーシナリオ(V、U、W、L)
7.2 ドライパウダー吸入器(DPI)セグメント市場予測、2022-2032年
7.2.1 DPIは他の吸入器より優れているため、普及が進むと予想される
7.2.2 回復のシナリオ(V、U、W、L)
7.3 ネブライザーセグメント市場予測、2022年〜2032年
7.3.1 ネブライザーは、嚢胞性線維症やCOPDなど、肺に大量に投与する疾患に対して特に有効
7.3.2 リカバリーシナリオ(V、U、W、L)
7.4 その他セグメント市場予測、2022-2032年
7.4.1 アクセサリーの需要増がセグメント成長を促進する見込み
7.4.2 リカバリーシナリオ(V, U, W, L)
8 呼吸器用ネブライザー市場予測、タイプ別 2022-2032年
8.1 ソフトミストネブライザーの市場予測、2022-2032年
8.1.1 携帯型デバイスの需要増が市場成長を後押し
8.1.2 リカバリーシナリオ(V、U、W、L)
8.2 ジェット噴霧器セグメント市場予測、2022年~2032年
8.2.1 小児患者への普及が市場成長を促進する見込み
8.2.2 リカバリーシナリオ(V、U、W、L)
8.3 超音波ネブライザーセグメント市場予測、2022年〜2032年
8.3.1 ローカライズされたプレイヤーによる幅広い製品ラインナップの存在
8.3.2 回復シナリオ(V、U、W、L)
9 世界の呼吸器用薬物送達技術市場予測、キャニスタータイプ別 2022-2032年
9.1 プレーンキャニスターのセグメント。売上高予測 2022-2032
9.1.1 シェアNo.1を獲得したプレーンキャニスター
9.1.2 回復予測(V、U、W、L)
9.2 コーティングキャニスターセグメント。売上高予測 2022-2032
9.2.1 薬物組成を維持できるコート付きキャニスターの需要は高い
9.2.2 回復予測 (V, U, W, L)
10 世界の呼吸器用薬物送達技術市場予測、用途別 2022-2032年
10.1 喘息セグメント。収益予測 2022-2032
10.1.1 喘息の有病率上昇がセグメント成長を牽引
10.1.2 リカバリー予測(V、U、W、L)
10.2 COPDセグメント。売上高予測 2022-2032
10.2.1 COPDの認知度向上が市場成長を牽引
10.2.2 回復予測(V、U、W、L)
10.3 嚢胞性線維症セグメント。売上高予測 2022-2032
10.3.1 嚢胞性線維症は米国の白人人口に多い遺伝性疾患である
10.3.2 回復予測(V、U、W、L)
10.4 その他セグメント。収益予測 2022-2032
10.4.1 先進呼吸器疾患治療薬のアライアンス適用拡大がその他セグメントの成長を促進する
10.4.2 回復予測(V, U, W, L)
11 呼吸器用薬物送達技術市場予測、エンドユーザー別 2022-2032年
11.1 在宅医療セグメント市場予測、2022-2032年
11.1.1 コビドパンデミックによる導入の増加
11.1.2 回復シナリオ(V、U、W、L)
11.2 病院・診療所セグメントの市場予測、2022年~2032年
11.2.1 第2位の売上高を誇るセグメント
11.2.2 回復シナリオ(V, U, W, L)
11.3 その他セグメント市場予測、2022-2032年
11.3.1 レスキューインハレーションデバイスの需要増
11.3.2 回復シナリオ (V, U, W, L)
12 呼吸器系薬物送達技術の全米市場予測、2022-2032年
12.1 呼吸器系薬物送達技術の世界地域別市場予測 2022-2032
12.1 回復シナリオ(V、U、W、L)
13 北米の呼吸器系薬物送達技術市場、2022-2032年
13.1 北米は世界市場最大の売上高を誇る地域
13.2 北米呼吸器官用薬物送達技術市場の国別予測(2022年~2032年)
13.3 北米呼吸器系薬物送達技術市場の製品別予測
13.3.1 回復シナリオ(V、U、W、L)。北米の呼吸器官用薬物送達技術市場:試験タイプ別予測、2022-2032年
13.4 北米呼吸器官用薬物送達製剤のタイプ別市場予測
13.4.1 回復シナリオ(V、U、W、L)。北米の呼吸器官用薬物送達製剤のタイプ別市場予測(2022年~2032年)
13.5 北米呼吸器官用薬物送達デバイスのタイプ別市場予測
13.5.1 回復シナリオ(V、U、W、L)。北米の呼吸器用薬物送達デバイスのタイプ別市場予測(2022年~2032年)
13.6 北米の呼吸器用ネブライザーのタイプ別市場予測
13.6.1 回復シナリオ(V、U、W、L)。北米の呼吸器用ネブライザーのタイプ別市場予測(2022年〜2032年)
13.7 呼吸器用薬物送達デバイスの北米市場:キャニスタータイプ別市場予測
13.7.1 回復シナリオ(V、U、W、L)。北米の呼吸器用薬物送達装置のエンドユーザー別市場予測(2022年~2032年)
13.8 北米の呼吸器用薬物送達デバイスの用途別市場予測
13.8.1 回復シナリオ(V,U,W,L)。北米の呼吸器官用薬物送達デバイスの用途別市場予測(2022-2032年)
13.9 北米の呼吸器系薬物送達デバイスのエンドユーザー別市場予測
13.9.1 回復シナリオ(V,U,W,L)。北米の呼吸器用薬物送達デバイスのエンドユーザー別市場予測(2022年~2032年)
13.10 米国の呼吸器系薬物送達技術市場予測(2022年~2032年)
13.10.1 リーディングプレイヤーの存在が米国呼吸器官用薬物送達技術市場を牽引する大きな要因
13.10.2 R&D投資とアウトソーシング活動の拡大
13.10.3 回復シナリオ(V、U、W、L)。10.3 回復シナリオ(V、U、W、L):米国呼吸器系薬物送達技術市場予測、2022年~2032年
13.11 カナダ呼吸器系薬物送達技術市場予測、2022年~2032年
13.11.1 北米地域で最も急成長すると予測されるカナダ市場
13.11.2 薬物送達技術の進歩のためのカナダの研究開発イニシアチブの高まりが成長を加速する
13.11.3 回復のシナリオ(V、U、W、L)。カナダの呼吸器系薬物送達技術の市場予測、2022-2032年
14 欧州の呼吸器系薬物送達技術市場、2022-2032年
14.1 世界市場で2番目に売上高が大きい地域
14.2 欧州呼吸器官用薬物送達技術国別市場予測(2022-2032年)
14.3 欧州呼吸器官用薬物送達技術市場 製品別予測
14.3.1 回復シナリオ(V、U、W、L)。欧州呼吸器官用ドラッグデリバリーテクノロジーのスタディタイプ別市場予測(2022年~2032年)
14.4 欧州呼吸器官用薬物送達製剤のタイプ別市場予測
14.4.1 回復シナリオ(V,U,W,L)。欧州呼吸器官用薬物送達製剤のタイプ別市場予測(2022年~2032年)
14.5 欧州呼吸器官用薬物送達デバイスのタイプ別市場予測
14.5.1 回復シナリオ(V、U、W、L)。欧州呼吸器用薬物送達デバイスのタイプ別市場予測(2022年~2032年)
14.6 呼吸器用ネブライザーのタイプ別欧州市場予測
14.6.1 回復シナリオ(V, U, W, L):欧州の呼吸器用ネブライザーのタイプ別市場予測(2022年~2032年)
14.7 呼吸器用薬物送達デバイスの欧州市場:キャニスタータイプ別予測
14.7.1 回復シナリオ(V、U、W、L)。欧州呼吸器用薬物送達デバイスのエンドユーザー別市場予測(2022年~2032年)
14.8 欧州呼吸器官用薬物送達デバイスの用途別市場予測
14.8.1 回復シナリオ(V、U、W、L)。欧州呼吸器用薬物送達デバイスの用途別市場予測(2022年~2032年
14.9 欧州の呼吸器系薬物送達デバイスのエンドユーザー別市場予測
14.9.1 回復シナリオ(V,U,W,L)。欧州呼吸器官用薬物送達デバイスのエンドユーザー別市場予測(2022年~2032年
14.10 ドイツ 呼吸器系薬物送達技術市場予測(2022年~2032年)
14.10.1 ドイツには世界最大級の製薬・医療機器企業が存在する
14.10.2 ドイツには確立された医療制度があり、医薬品分野で戦略的な位置づけにある
14.10.3 回復シナリオ(V、U、W、L)。10.3 回復シナリオ(V、U、W、L):ドイツ呼吸器用薬物送達技術市場予測、2022-2032年
14.11 英国 呼吸器系薬物送達技術市場予測、2022年~2032年
14.11.1 整備されたR&Dインフラの存在
14.11.2 英国は吸入薬・ドラッグデリバリーシステムの生産・開発のハブとなってきた
14.11.3 回復シナリオ(V、U、W、L)。11.3 回復シナリオ(V、U、W、L):英国呼吸器用薬物送達技術市場予測、2022-2032年
14.12 フランス呼吸器系薬物送達技術市場予測、2022年〜2032年
14.12.1 主要企業による薬剤の研究開発・製造におけるフランスへの好感度上昇
14.12.2 高度な医療サービスに対する需要の高まり
14.12.3 回復シナリオ(V、U、W、L):12.3 回復シナリオ(V、U、W、L):フランス呼吸器系薬物送達技術市場予測、2022-2032年
14.13 イタリア 呼吸器系薬物送達技術の市場予測、2022年~2032年
14.13.1 医薬品製造ハブ
14.13.2 イタリアの呼吸器系薬物送達技術市場は欧州地域内第4位の市場規模
14.13.3 回復シナリオ(V、U、W、L)。13.3 回復シナリオ(V、U、W、L):イタリアの呼吸器系薬物送達技術市場予測、2022年~2032年
14.14 スペイン 呼吸器系薬物送達技術市場予測、2022年〜2032年
14.14.1 医薬品需要は製薬業界の成長に影響される
14.14.2 強く成長するスペイン経済
14.14.3 回復シナリオ(V、U、W、L)。14.3 回復シナリオ(V、U、W、L):スペイン 呼吸器系薬物送達技術市場予測、2022-2032年
14.15 ロシア 呼吸器系薬物送達技術市場予測、2022年〜2032年
14.15.1 アンメット医薬品ニーズ
14.15.2 回復シナリオ(V、U、W、L)。15.2 回復シナリオ(V、U、W、L):ロシア呼吸器系薬物送達技術市場予測、2022年~2032年
14.16 欧州以外の呼吸器系薬物送達技術の市場予測、2022年~2032年
14.16.1 慢性疾患の増加が同地域の市場成長を牽引
14.16.2 回復シナリオ(V、U、W、L)。16.2 回復シナリオ(V、U、W、L):その他の欧州の呼吸器系薬物送達技術の市場予測、2022年~2032年
15 アジア太平洋地域の呼吸器系薬物送達技術市場、2022-2032年
15.1 急成長しているのはアジア太平洋地域
15.2 アジア太平洋地域の呼吸器系薬物送達技術市場の国別予測(2022年~2032年)
15.3 アジア太平洋地域の呼吸器官用薬物送達技術市場の製品別予測
15.3.1 回復シナリオ(V、U、W、L)。アジア太平洋地域の呼吸器官用薬物送達技術市場:試験タイプ別予測、2022-2032年
15.4 アジア太平洋地域の呼吸器官用薬物送達製剤のタイプ別市場予測
15.4.1 回復シナリオ(V、U、W、L)。アジア太平洋地域の呼吸器官用薬物送達製剤のタイプ別市場予測(2022年~2032年)
15.5 アジア太平洋地域の呼吸器官用薬物送達デバイスのタイプ別市場予測
15.5.1 回復シナリオ(V、U、W、L)。アジア太平洋地域の呼吸器用薬物送達デバイスのタイプ別市場予測(2022年~2032年)
15.6 アジア太平洋地域の呼吸器用ネブライザーのタイプ別市場予測
15.6.1 回復シナリオ(V、U、W、L)。アジア太平洋地域の呼吸器用ネブライザーのタイプ別市場予測(2022年~2032年)
15.7 アジア太平洋地域の呼吸器用薬物送達デバイスの市場予測(キャニスタータイプ別
15.7.1 回復シナリオ(V、U、W、L)。アジア太平洋地域の呼吸器官用薬物送達装置のエンドユーザー別市場予測(2022-2032年)
15.8 アジア太平洋地域の呼吸器官用薬物送達デバイスの用途別市場予測
15.8.1 回復シナリオ(V、U、W、L)。アジア太平洋地域の呼吸器官用薬物送達デバイスの用途別市場予測(2022年~2032年)
15.9 アジア太平洋地域の呼吸器官用薬物送達デバイスのエンドユーザー別市場予測
15.9.1 回復シナリオ(V,U,W,L)。アジア太平洋地域の呼吸器用薬物送達技術市場予測(エンドユーザー別、2022年~2032年
15.10 日本 呼吸器系薬物送達技術市場予測(2022年~2032年
15.10.1 アジア太平洋地域で日本が最大の市場シェアを占める
15.10.2 日本では医薬品開発のアウトソーシングが増加し、市場成長を促進
15.10.3 回復シナリオ(V、U、W、L)。10.3 回復シナリオ(V、U、W、L):日本の呼吸器系薬物送達技術市場予測、2022-2032年
15.11 中国 呼吸器系薬物送達技術市場予測、2022年〜2032年
15.11.1 市場プレイヤーによる戦略的イニシアティブ
15.11.2 中国における医療費支出の増加
15.11.3 回復シナリオ(V、U、W、L)。11.3 回復シナリオ(V、U、W、L):中国呼吸器系薬物送達技術市場予測、2022-2032年
15.12 インドの呼吸器系薬物送達技術の市場予測、2022年~2032年
15.12.1 発展する医療インフラ
15.12.2 インドの製薬業界に対する政府支援
15.12.3 回復シナリオ(V、U、W、L)。12.3 回復シナリオ(V、U、W、L):インド呼吸器系薬物送達技術市場予測、2022年~2032年
15.13 オーストラリア 呼吸器系薬物送達技術の市場予測、2022年~2032年
15.13.1 オーストラリアは高水準のR&D活動を行うことで有名
15.13.2 ハイエンドな医療インフラの利用可能性
15.13.3 回復シナリオ(V、U、W、L)。13.3 回復シナリオ(V、U、W、L):オーストラリア呼吸器官用薬物送達技術市場予測、2022-2032年
15.14 韓国 呼吸器系薬物送達技術の市場予測、2022年~2032年
15.14.1 呼吸器疾患の有病率の増加と有利な政府政策の存在
15.14.2 熟練労働者の存在と有利なR&Dシナリオ
15.14.3 回復シナリオ(V、U、W、L)。韓国 呼吸器官用薬物送達技術市場の予測、2022年~2032年
15.15 アジア太平洋地域の呼吸器系薬物送達技術の市場予測、2022年~2032年
15.15.1 可処分所得の増加
15.15.2 回復シナリオ(V、U、W、L)。15.2 回復シナリオ(V、U、W、L):その他のアジア地域の呼吸器系薬物送達技術の市場予測、2022年~2032年
16 中南米 呼吸器系薬物送達技術市場、2022-2032年
16.1 中南米の呼吸器官用薬物送達技術市場
16.2 中南米呼吸器系薬物送達技術市場の国別予測(2022年~2032年
16.3 中南米の呼吸器系薬物送達技術市場の製品別予測
16.3.1 回復シナリオ(V、U、W、L)。中南米の呼吸器官用薬物送達技術市場予測(試験タイプ別):2022-2032年
16.4 中南米の呼吸器官用薬物送達製剤のタイプ別市場予測
16.4.1 回復シナリオ(V,U,W,L)。中南米の呼吸器官用薬物送達製剤のタイプ別市場予測(2022年~2032年
16.5 中南米の呼吸器官用薬物送達デバイスのタイプ別市場予測
16.5.1 回復シナリオ(V、U、W、L)。中南米の呼吸器用薬物送達デバイスのタイプ別市場予測(2022年~2032年
16.6 中南米の呼吸器用ネブライザーのタイプ別市場予測
16.6.1 回復シナリオ(V、U、W、L)。中南米の呼吸器用ネブライザーのタイプ別市場予測(2022-2032年
16.7 中南米の呼吸器用薬物送達デバイスの市場予測(キャニスタータイプ別
16.7.1 回復シナリオ(V、U、W、L)。中南米の呼吸器用薬物送達技術市場予測(エンドユーザー別、2022年~2032年
16.8 中南米の呼吸器用薬物送達デバイスの用途別市場予測
16.8.1 回復シナリオ(V、U、W、L)。中南米の呼吸器官用薬物送達デバイスの用途別市場予測(2022-2032年
16.9 中南米の呼吸器用薬物送達デバイスのエンドユーザー別市場予測
16.9.1 回復シナリオ(V,U,W,L)。中南米の呼吸器用薬物送達技術市場予測(エンドユーザー別、2022年~2032年
16.10 ブラジル呼吸器系薬物送達技術市場予測(2022年~2032年
16.10.1 ラテンアメリカで最も成長率の高い経済圏
16.10.2 高いポテンシャルの製造環境
16.10.3 回復シナリオ(V、U、W、L)。10.3 回復シナリオ(V、U、W、L):ブラジル 呼吸器系薬物送達技術市場予測、2022年~2032年
16.11 メキシコ 呼吸器系薬物送達技術市場予測、2022年~2032年
16.11.1 米国より低い製造コスト
16.11.2 未開拓の市場機会の存在
16.11.3 回復シナリオ(V, U, W, L)。メキシコの呼吸器官用薬物送達技術市場予測、2022年~2032年
16.12 その他のラテンアメリカの呼吸器系薬物送達技術市場予測、2022年~2032年
16.12.1 進化するラテンアメリカの医療インフラ
16.12.2 回復シナリオ(V、U、W、L)。12.2 中南米の残りの呼吸器系薬物送達技術市場予測、2022年~2032年
17 MEAの呼吸器系薬物送達技術市場、2022-2032年
17.1 MEA地域における慢性呼吸器疾患の有病率の上昇
17.2 MEA呼吸器系薬物送達技術市場の国別予測(2022年~2032年)
17.3 MEA呼吸器系薬物送達技術市場の製品別予測
17.3.1 回復シナリオ(V、U、W、L)。MEA呼吸器官用薬物送達技術の試験タイプ別市場予測(2022-2032年)
17.4 MEA呼吸器官用薬物送達製剤のタイプ別市場予測
17.4.1 回復シナリオ(V、U、W、L)。MEA呼吸器官用薬物送達製剤のタイプ別市場予測(2022-2032年)
17.5 MEA呼吸器官用薬物送達デバイスのタイプ別市場予測
17.5.1 回復シナリオ(V、U、W、L)。MEA呼吸器用薬物送達デバイスのタイプ別市場予測(2022年-2032年)
17.6 MEAの呼吸器用ネブライザーのタイプ別市場予測
17.6.1 回復シナリオ(V、U、W、L)。MEA呼吸器用ネブライザーのタイプ別市場予測(2022-2032年)
17.7 MEAの呼吸器用薬物送達デバイスのタイプ別市場予測
17.7.1 回復シナリオ(V、U、W、L)。MEA呼吸器用薬物送達装置のエンドユーザー別市場予測(2022-2032年)
17.8 MEA呼吸器用薬物送達デバイスの用途別市場予測
17.8.1 回復シナリオ(V、U、W、L)。MEA呼吸器用薬物送達デバイスの用途別市場予測(2022-2032年)
17.9 MEAの呼吸器用薬物送達デバイスのエンドユーザー別市場予測
17.9.1 回復シナリオ(V、U、W、L)。MEA呼吸器用薬物送達デバイスのエンドユーザー別市場予測(2022-2032年)
17.10 南アフリカの呼吸器系薬物送達技術市場予測(2022年~2032年)
17.10.1 南アフリカにおける喘息の有病率は急速に増加している
17.10.2 鉱業と有利なイニシアチブの存在による対象人口の増加
17.10.3 回復シナリオ(V、U、W、L)。南アフリカの呼吸器官用薬物送達技術市場予測、2022-2032年
17.11 GCC呼吸器系薬物送達技術の市場予測、2022年~2032年
17.11.1 巨大な成長機会の存在
17.11.2 個別化医療と在宅医療の進展がもたらすパラダイムチェンジ
17.11.3 回復シナリオ(V、U、W、L)。GCCの呼吸器官用薬物送達技術の市場予測、2022-2032年
17.12 その他のMEAの呼吸器系薬物送達技術市場予測、2022年~2032年
17.12.1 呼吸器系疾患の負担増と国際企業からの投資増加
17.12.2 広範なタバコの使用による呼吸器疾患の発生率の増加
17.12.3 回復シナリオ(V、U、W、L)。その他のMEAの呼吸器系薬物送達技術市場予測、2022-2032年
18 企業のプロファイル:呼吸器系薬物送達技術市場
18.1 呼吸器系薬物送達技術市場。企業シェア分析
18.2 呼吸器系ドラッグデリバリーテクノロジー市場の最新動向、2018-2022年
18.3 グラクソ・スミスクラインPLC
18.3.1 企業スナップショット
18.3.2 会社概要
18.3.3 財務分析
18.3.3.1 純収益、2017年-2021年
18.3.3.2 地域別収益/マーケットシェア、2021年
18.3.3.3 セグメント別収益/マーケットシェア、2021年
18.3.4 製品ベンチマーク
18.3.5 最近の開発状況、2018-2021年
18.4 フィリップス・レスピロニクス
18.4.1 企業スナップショット
18.4.2 会社概要
18.4.3 財務分析
18.4.3.1 純収益、2017-2021年
18.4.3.2 地域別収益/市場シェア、2021年
18.4.3.3 セグメント別収益/マーケットシェア、2021年
18.4.4 製品ベンチマーク
18.5 ベーリンガーインゲルハイムGmbH
18.5.1 企業スナップショット
18.5.2 会社概要
18.5.3 財務分析
18.5.3.1 純収益、2017-2021年
18.5.3.2 地域別収益/マーケットシェア、2021年
18.5.3.3 セグメント別収益/マーケットシェア、2021年
18.5.4 製品ベンチマーク
18.5.5 最近の開発状況、2018-2021年
18.6 3Mヘルスケア
18.6.1 企業スナップショット
18.6.2 会社概要
18.6.3 財務分析
18.6.3.1 純収益、2017-2021年
10.2.1.1 地域別収益/マーケットシェア、2021年
18.6.3.2 セグメント別収益/マーケットシェア、2021年
18.6.4 製品ベンチマーク
18.6.5 最近の開発状況、2018-2021年
18.7 アストラゼネカplc
18.7.1 企業スナップショット
18.7.2 会社概要
18.7.3 財務分析
18.7.3.1 純収益、2017-2021年
18.7.3.2 地域別収益/市場シェア、2021年
18.7.3.3 セグメント別収益/マーケットシェア、2021年
18.7.4 製品ベンチマーク
18.7.5 最近の開発状況、2018-2021年
18.8 メルク・アンド・カンパニー
18.8.1 企業スナップショット
18.8.2 会社概要
18.8.3 財務分析
18.8.3.1 純収益、2017-2021年
18.8.3.2 地域別収益/マーケットシェア、2021年
18.8.3.3 セグメント別収益/マーケットシェア、2021年
18.8.4 製品のベンチマーキング
18.9 ノバルティスAG
18.9.1 企業スナップショット
18.9.2 会社概要
18.9.3 財務分析
18.9.3.1 純収益、2017-2021年
18.9.3.2 地域別収益/マーケットシェア、2021年
18.9.3.3 セグメント別収益/マーケットシェア、2021年
18.9.4 製品ベンチマーク
18.9.5 最近の開発状況、2018-2021年
18.10 オムロン株式会社
18.10.1 企業スナップショット
18.10.2 会社概要
18.10.3 財務分析
18.10.3.1 純収益、2017-2021年
18.10.3.2 地域別収益/マーケットシェア、2021年
18.10.3.3 セグメント別収益/マーケットシェア、2021年
18.10.4 製品ベンチマーク
18.10.5 最近の開発状況、2018-2021年
18.11 サノビオン・ファーマシューティカルズ・インク
18.11.1 企業スナップショット
18.11.2 会社概要
18.11.3 財務分析
18.11.3.1 純収益、2017-2021年
18.11.3.2 地域別収益/市場シェア、2021年
18.11.4 製品ベンチマーク
18.11.5 最近の開発状況、2018-2021年
18.12 テバ・ファーマシューティカルズ
18.12.1 企業スナップショット
18.12.2 会社概要
18.12.3 財務分析
18.12.3.1 純収益、2017-2021年
18.12.3.2 地域別収益/市場シェア、2021年
18.12.4 製品ベンチマーク
18.12.5 最近の開発状況、2018-2021年
18.13 シプラ・リミテッド
18.13.1 企業スナップショット
18.13.2 会社概要
18.13.3 財務分析
18.13.3.1 純収益、2017年-2021年
18.13.4 製品ベンチマーク
18.13.5 最近の開発状況、2018-2021年
18.14 レシプファームAb.
18.14.1 企業スナップショット
18.14.2 会社概要
18.14.3 財務分析
18.14.3.1 純収益、2016年~2020年
18.14.3.2 地域別収益/マーケットシェア、2021年
18.14.4 セグメント別収益/マーケットシェア、2021年
18.14.5 製品ベンチマーク
18.14.6 最近の開発状況、2018-2021年
18.15 メディサナGmbH.
18.15.1 企業スナップショット
18.15.2 会社概要
18.15.3 製品ベンチマーク
18.16 グラハムフィールドヘルスプロダクツ
18.16.1 企業スナップショット
18.16.2 会社概要
18.16.3 製品ベンチマーク
18.17 アプターグループ
18.17.1 企業スナップショット
18.17.2 会社概要
18.17.3 財務分析
18.17.3.1 純収益、2017-2021年
18.17.3.2 地域別収益/市場シェア、2021年
18.17.4 セグメント別収益/マーケットシェア、2021年
18.17.5 製品ベンチマーク
18.17.6 最近の開発状況、2018-2021年
19 結論と提言
19.1 ヴィジョンゲインからの結論
19.2 市場関係者への提言
19.3 主要地域と急成長地域(北米地域が最大の市場シェアを占める)
表の一覧
Figure 1 Global Respiratory Drug Delivery Technologies Market Size Forecast 2022-2032 (US$bn, AGR %)
Figure 2 Global Respiratory Drug Delivery Technologies Market Segmentation
Figure 3 Global Respiratory Drug Delivery Technologies Market: Market Trends
Figure 4 Barriers of Respiratory Drugs Delivery
Figure 5 Global Respiratory Drug Delivery Technologies Market: SWOT Analysis
Figure 6 Global Respiratory Drug Delivery Technologies Market: Porter’s Five Forces Analysis
Figure 7 Global Respiratory Drug Delivery Technologies Market: PEST Analysis
Figure 8 Global Respiratory Drug Delivery Technologies Market Size Forecast 2022-2032 (US$bn, AGR %)
Figure 9 Global Respiratory Drug Delivery Technologies Market Size Forecast 2022-2032 (US$bn, AGR %): "V" Shaped Recovery
Figure 10 Global Respiratory Drug Delivery Technologies Market Size Forecast 2022-2032 (US$bn, AGR %): "U" Shaped Recovery
Figure 11 Global Respiratory Drug Delivery Technologies Market Size Forecast 2022-2032 (US$bn, AGR %): "W" Shaped Recovery
Figure 12 Global Respiratory Drug Delivery Technologies Market Size Forecast 2022-2032 (US$bn, AGR %): "L" Shaped Recovery
Figure 13 Global Respiratory drug delivery formulations Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 14 “V” Shaped Recovery: Global Respiratory drug delivery formulations Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 15 “U” Shaped Recovery: Global Respiratory drug delivery formulations Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 16 “W” Shaped Recovery: Global Respiratory drug delivery formulations Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 17 “L” Shaped Recovery: Global Respiratory drug delivery formulations Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 18 Global Respiratory Drug Delivery Devices Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 19 “V” Shaped Recovery: Global Respiratory Drug Delivery Devices Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 20 “U” Shaped Recovery: Global Respiratory Drug Delivery Devices Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 21 “W” Shaped Recovery: GlobalRespiratory Drug Delivery Devices Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 22 “L” Shaped Recovery: GlobalRespiratory Drug Delivery Devices Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 23 Global Respiratory Drug Delivery Formulation Market Share Forecast by Type, 2021, 2026, 2032 (%)
Figure 24 Global Respiratory Drug Delivery Formulation Market for Dry Powder Formulation Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 25 Global Respiratory Drug Delivery Formulation Market for Dry Powder Formulation Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 26 Global Respiratory Drug Delivery Formulation Market for Dry Powder Formulation Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 27 Global Respiratory Drug Delivery Formulation Market for Dry Powder Formulation Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 28 Global Respiratory Drug Delivery Formulation Market for Dry Powder Formulation Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 29 Global Respiratory Drug Delivery Formulation Market for Suspension Aerosol Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 30 Global Respiratory Drug Delivery Formulation Market for Suspension Aerosol Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 31 Global Respiratory Drug Delivery Formulation Market for Suspension Aerosol Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 32 Global Respiratory Drug Delivery Formulation Market for Suspension Aerosol Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 33 Global Respiratory Drug Delivery Formulation Market for Suspension Aerosol Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 34 Global Respiratory Drug Delivery Formulation Market for Solution Aerosol Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 35 Global Respiratory Drug Delivery Formulation Market for Solution Aerosol Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 36 Global Respiratory Drug Delivery Formulation Market for Solution Aerosol Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 37 Global Respiratory Drug Delivery Formulation Market for Solution Aerosol Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 38 Global Respiratory Drug Delivery Formulation Market for Solution Aerosol Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 39 Global Respiratory Drug Delivery Formulation Market Share Forecast by Type, 2021, 2026, 2032(%)
Figure 40 Global Respiratory Drug Delivery Formulation Market for Metered Dose Inhalers (MDIS) Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 41 Global Respiratory Drug Delivery Formulation Market for Metered Dose Inhalers (MDIS) Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 42 Global Respiratory Drug Delivery Formulation Market for Metered Dose Inhalers (MDIS) Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 43 Global Respiratory Drug Delivery Formulation Market for Metered Dose Inhalers (MDIS) Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 44 Global Respiratory Drug Delivery Formulation Market for Metered Dose Inhalers (MDIS) Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 45 Global Respiratory Drug Delivery Formulation Market for Dry Powder Inhalers (DPIS) Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 46 Global Respiratory Drug Delivery Formulation Market for Dry Powder Inhalers (DPIS) Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 47 Global Respiratory Drug Delivery Formulation Market for Dry Powder Inhalers (DPIS) Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 48 Global Respiratory Drug Delivery Formulation Market for Dry Powder Inhalers (DPIS) Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 49 Global Respiratory Drug Delivery Formulation Market for Dry Powder Inhalers (DPIS) Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 50 Global Respiratory Drug Delivery Formulation Market for Nebulizers Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 51 Global Respiratory Drug Delivery Formulation Market for Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 52 Global Respiratory Drug Delivery Formulation Market for Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 53 Global Respiratory Drug Delivery Formulation Market for Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 54 Global Respiratory Drug Delivery Formulation Market for Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 55 Global Respiratory Drug Delivery Formulation Market for Others Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 56 Global Respiratory Drug Delivery Formulation Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 57 Global Respiratory Drug Delivery Formulation Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 58 Global Respiratory Drug Delivery Formulation Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 59 Global Respiratory Drug Delivery Formulation Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 60 Global Respiratory Nebulizers Market Share Forecast by Type, (%)
Figure 61 Global Respiratory Nebulizers Market for Soft Mist Nebulizers Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 62 Global Respiratory Nebulizers Market for Soft Mist Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 63 Global Respiratory Nebulizers Market for Soft Mist Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 64 Global Respiratory Nebulizers Market for Soft Mist Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 65 Global Respiratory Nebulizers Market for Soft Mist Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 66 Global Respiratory Nebulizers Market for Jet Nebulizers Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 67 Global Respiratory Nebulizers Market for Jet Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 68 Global Respiratory Nebulizers Market for Jet Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 69 Global Respiratory Nebulizers Market for Jet Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 70 Global Respiratory Nebulizers Market for Jet Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 71 Global Respiratory Nebulizers Market for Ultrasonic Nebulizers Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 72 Global Respiratory Nebulizers Market for Ultrasonic Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 73 Global Respiratory Nebulizers Market for Ultrasonic Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 74 Global Respiratory Nebulizers Market for Ultrasonic Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 75 Global Respiratory Nebulizers Market for Ultrasonic Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 76 Global Plain Canisters Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 77 “V” Shaped Recovery: Global Plain Canisters Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 78 “U” Shaped Recovery: Global Plain Canisters Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 79 “W” Shaped Recovery: Global Plain Canisters Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 80 “L” Shaped Recovery: Global Plain Canisters Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 81 Global Coated Canister Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 82 “V” Shaped Recovery: Global Coated Canister Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 83 “U” Shaped Recovery: GlobalCoated Canister Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 84 “W” Shaped Recovery: GlobalCoated Canister Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 85 “L” Shaped Recovery: Global Coated Canister Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 86 Global Respiratory Drug Delivery Technologies Market Share Forecast by Application, 2021, 2026, 2032(%)
Figure 87 Global Asthma Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 88 “V” Shaped Recovery: Global Asthma Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 89 “U” Shaped Recovery: Global Asthma Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 90 “W” Shaped Recovery: Global Asthma Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 91 “L” Shaped Recovery: Global Asthma Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 92 Global COPD Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 93 “V” Shaped Recovery: Global COPD Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 94 “U” Shaped Recovery: Global COPD Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 95 “W” Shaped Recovery: Global COPD Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 96 “L” Shaped Recovery: Global COPD Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 97 Global Cystic Fibrosis Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 98 “V” Shaped Recovery: Global Cystic Fibrosis Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 99 “U” Shaped Recovery: Global Cystic Fibrosis Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 100 “W” Shaped Recovery: Global Cystic Fibrosis Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 101 “L” Shaped Recovery: Global Cystic Fibrosis Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 102 Global Others Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 103 “V” Shaped Recovery: Global Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 104 “U” Shaped Recovery: Global Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 105 “W” Shaped Recovery: Global Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 106 “L” Shaped Recovery: Global Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 107 Global Respiratory Drug Delivery Technologies Market Share Forecast by End-User, 2021, 2026, 2032(%)
Figure 108 Global Respiratory Drug Delivery Technologies Market for Homecare Settings Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 109 Global Respiratory Drug Delivery Technologies Market for Homecare Settings Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 110 Global Respiratory Drug Delivery Technologies Market for Homecare Settings Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 111 Global Respiratory Drug Delivery Technologies Market for Homecare Settings Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 112 Global Respiratory Drug Delivery Technologies Market for Homecare Settings Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 113 Global Respiratory Drug Delivery Technologies Market for Hospitals & Clinics Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 114 Global Respiratory Drug Delivery Technologies Market for Hospitals & Clinics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 115 Global Respiratory Drug Delivery Technologies Market for Hospitals & Clinics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 116 Global Respiratory Drug Delivery Technologies Market for Hospitals & Clinics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 117 Global Respiratory Drug Delivery Technologies Market for Hospitals & Clinics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 118 Global Respiratory Drug Delivery Technologies Market for Others Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 119 Global Respiratory Drug Delivery Technologies Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 120 Global Respiratory Drug Delivery Technologies Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 121 Global Respiratory Drug Delivery Technologies Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 122 Global Respiratory Drug Delivery Technologies Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 123 Global Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion)
Figure 124 Global Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion): “V” Shaped Recovery
Figure 125 Global Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion): “U” Shaped Recovery
Figure 126 Global Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 127 Global Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 128 North America Respiratory Drug Delivery Technologies Market Forecast 2022-2032 (US$ billion, AGR %)
Figure 129 North America Respiratory Drug Delivery Technologies Market Forecast by Country 2022-2032 (US$ billion)
Figure 130 North America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion)
Figure 131 North America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 132 North America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 133 North America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 134 North America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 135 North America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion)
Figure 136 North America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 137 North America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 138 North America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 139 North America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 140 North America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 141 North America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 142 North America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 143 North America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 144 North America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 145 North America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion)
Figure 146 North America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 147 North America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "U” Shaped Recovery
Figure 148 North America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 149 North America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 150 North America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 151 North America Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 152 North America Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 153 North America Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 154 North America Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 155 North America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 156 North America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 157 North America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 158 North America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 159 North America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 160 North America Respiratory Drug Delivery Devices Market Forecast by End User, 2022-2032 (US$ billion)
Figure 161 North America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 162 North America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 163 North America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 164 North America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 165 U.S. Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 166 U.S. Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 167 U.S. Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 168 U.S. Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 169 U.S. Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 170 Canada Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 171 Canada Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 172 Canada Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 173 Canada Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 174 Canada Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 175 Europe Respiratory Drug Delivery Technologies Market Forecast 2022-2032 (US$ billion, AGR%)
Figure 176 Europe Respiratory Drug Delivery Technologies Market Forecast by Country 2022-2032 (US$ billion)
Figure 177 Europe Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion)
Figure 178 Europe Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 179 Europe Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 180 Europe Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 181 Europe Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 182 Europe Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion)
Figure 183 Europe Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 184 Europe Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 185 Europe Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 186 Europe Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 187 Europe Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 188 Europe Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 189 Europe Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 190 Europe Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 191 Europe Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 192 Europe Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion)
Figure 193 Europe Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 194 Europe Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "U” Shaped Recovery
Figure 195 Europe Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 196 Europe Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 197 Europe Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 198 Europe Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 199 Europe Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 200 Europe Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 201 Europe Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 202 Europe Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 203 Europe Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 204 Europe Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 205 Europe Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 206 Europe Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 207 Europe Respiratory Drug Delivery Devices Market Forecast by End User, 2022-2032 (US$ billion)
Figure 208 Europe Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 209 Europe Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 210 Europe Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 211 Europe Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 212 Germany Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 213 Germany Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 214 Germany Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 215 Germany Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 216 Germany Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 217 UK Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 218 UK Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 219 UK Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 220 UK Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 221 UK Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 222 France Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 223 France Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 224 France Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 225 France Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 226 France Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 227 Italy Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 228 Italy Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 229 Italy Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 230 Italy Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 231 Italy Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 232 Spain Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 233 Spain Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 234 Spain Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 235 Spain Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 236 Spain Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 237 Russia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 238 Russia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 239 Russia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 240 Russia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 241 Russia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 242 Rest of Europe Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 243 Rest of Europe Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 244 Rest of Europe Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 245 Rest of Europe Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 246 Rest of Europe Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 247 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast 2022-2032 (US$ billion, AGR %)
Figure 248 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Country 2022-2032 (US$ billion)
Figure 249 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion)
Figure 250 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 251 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 252 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 253 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 254 Asia Pacific Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion)
Figure 255 Asia Pacific Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 256 Asia Pacific Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 257 Asia Pacific Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 258 Asia Pacific Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 259 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 260 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 261 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 262 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 263 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 264 Asia Pacific Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion)
Figure 265 Asia Pacific Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 266 Asia Pacific Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "U” Shaped Recovery
Figure 267 Asia Pacific Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 268 Asia Pacific Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 269 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 270 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 271 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 272 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 273 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 274 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 275 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 276 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 277 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 278 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 279 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by End User, 2022-2032 (US$ billion)
Figure 280 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 281 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 282 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 283 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 284 Japan Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 285 Japan Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 286 Japan Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 287 Japan Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 288 Japan Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 289 China Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 290 China Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 291 China Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 292 China Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 293 China Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 294 India Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 295 India Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 296 India Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 297 India Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 298 India Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 299 Australia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 300 Australia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 301 Australia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 302 Australia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 303 Australia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 304 South Korea Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 305 South Korea Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 306 South Korea Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 307 South Korea Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 308 South Korea Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 309 Rest of Asia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 310 Rest of Asia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 311 Rest of Asia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 312 Rest of Asia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 313 Rest of Asia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 314 Latin America Respiratory Drug Delivery Technologies Market Forecast 2022-2032 (US$ billion, AGR%)
Figure 315 Latin America Respiratory Drug Delivery Technologies Market Forecast by Country 2022-2032 (US$ billion)
Figure 316 Latin America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion)
Figure 317 Latin America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 318 Latin America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 319 Latin America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 320 Latin America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 321 Latin America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion)
Figure 322 Latin America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 323 Latin America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 324 Latin America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 325 Latin America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 326 Latin America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 327 Latin America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 328 Latin America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 329 Latin America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 330 Latin America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 331 Latin America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion)
Figure 332 Latin America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 333 Latin America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "U” Shaped Recovery
Figure 334 Latin America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 335 Latin America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 336 Latin America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 337 Latin America Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 338 Latin America Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 339 Latin America Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 340 Latin America Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 341 Latin America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 342 Latin America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 343 Latin America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 344 Latin America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 345 Latin America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 346 Latin America Respiratory Drug Delivery Devices Market Forecast by End User, 2022-2032 (US$ billion)
Figure 347 Latin America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 348 Latin America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 349 Latin America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 350 Latin America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 351 Brazil Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 352 Brazil Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 353 Brazil Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 354 Brazil Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 355 Brazil Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 356 Mexico Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 357 Mexico Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 358 Mexico Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 359 Mexico Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 360 Mexico Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 361 Rest of Latin America Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 362 Rest of Latin America Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 363 Rest of Latin America Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 364 Rest of Latin America Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 365 Rest of Latin America Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 366 MEA Respiratory Drug Delivery Technologies Market Forecast 2022-2032 (US$ billion, AGR%)
Figure 367 MEA Respiratory Drug Delivery Technologies Market Forecast by Country 2022-2032 (US$ billion)
Figure 368 MEA Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion)
Figure 369 MEA Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 370 MEA Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 371 MEA Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 372 MEA Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 373 MEA Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion)
Figure 374 MEA Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 375 MEA Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 376 MEA Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 377 MEA Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 378 MEA Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 379 MEA Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 380 MEA Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 381 MEA Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 382 MEA Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 383 MEA Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion)
Figure 384 MEA Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 385 MEA Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "U” Shaped Recovery
Figure 386 MEA Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 387 MEA Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 388 MEA Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 389 MEA Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 390 MEA Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 391 MEA Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 392 MEA Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 393 MEA Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 394 MEA Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 395 MEA Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 396 MEA Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 397 MEA Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 398 MEA Respiratory Drug Delivery Devices Market Forecast by End User, 2022-2032 (US$ billion)
Figure 399 MEA Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 400 MEA Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 401 MEA Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 402 MEA Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 403 South Africa Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 404 South Africa Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 405 South Africa Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 406 South Africa Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 407 South Africa Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 408 GCC Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 409 GCC Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 410 GCC Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 411 GCC Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 412 GCC Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 413 Rest of MEA Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 414 Rest of MEA Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 415 Rest of MEA Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 416 Rest of MEA Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 417 Rest of MEA Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 418 Respiratory Drug Delivery Technologies Market: Company Share Analysis, 2021
Figure 419 GSK Corporation: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 420 GSK Corporation: Regional Revenue Shares, 2021
Figure 421 GSK: Segmental Revenue Shares, 2021
Figure 422 Philips Respironics: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 423 Philips Respironics: Regional Revenue Shares, 2021
Figure 424 Philips Respironics: Segmental Revenue Shares, 2021
Figure 425 Boehringer Ingelheim GmbH: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 426 Boehringer Ingelheim GmbH: Regional Revenue Shares, 2021
Figure 430 AstraZeneca Plc: Net Revenue, 2017-2021 (US$ billion, AGR%)
Figure 431 AstraZeneca Plc: Regional Revenue Shares, 2021
Figure 432 AstraZeneca Plc: Segmental Revenue Shares, 2021
Figure 433 Merck & Co., Inc.: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 434 Merck & Co., Inc.: Regional Revenue Shares, 2021
Figure 435 Merck & Co., Inc.: Segmental Revenue Shares, 2021
Figure 436 Novartis AG: Net Revenue, 2017-2021 (US$ billion, AGR%)
Figure 437 Novartis AG: Regional Revenue Shares, 2021
Figure 438 Novartis AG: Segmental Revenue Shares, 2021
Figure 442 Sunovion pharmaceuticals: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 443 Sunovion pharmaceuticals: Regional Revenue Shares, 2021
Figure 453 Global Respiratory Drug Delivery Technologies Market Share Forecast by Product, 2021, 2027, 2032(%)
Figure 454 Global Respiratory Drug Delivery Technologies Market Share Forecast by Region, 2021, 2026, 2032(%)
図の一覧
Figure 1 Global Respiratory Drug Delivery Technologies Market Size Forecast 2022-2032 (US$bn, AGR %)
Figure 2 Global Respiratory Drug Delivery Technologies Market Segmentation
Figure 3 Global Respiratory Drug Delivery Technologies Market: Market Trends
Figure 4 Barriers of Respiratory Drugs Delivery
Figure 5 Global Respiratory Drug Delivery Technologies Market: SWOT Analysis
Figure 6 Global Respiratory Drug Delivery Technologies Market: Porter’s Five Forces Analysis
Figure 7 Global Respiratory Drug Delivery Technologies Market: PEST Analysis
Figure 8 Global Respiratory Drug Delivery Technologies Market Size Forecast 2022-2032 (US$bn, AGR %)
Figure 9 Global Respiratory Drug Delivery Technologies Market Size Forecast 2022-2032 (US$bn, AGR %): "V" Shaped Recovery
Figure 10 Global Respiratory Drug Delivery Technologies Market Size Forecast 2022-2032 (US$bn, AGR %): "U" Shaped Recovery
Figure 11 Global Respiratory Drug Delivery Technologies Market Size Forecast 2022-2032 (US$bn, AGR %): "W" Shaped Recovery
Figure 12 Global Respiratory Drug Delivery Technologies Market Size Forecast 2022-2032 (US$bn, AGR %): "L" Shaped Recovery
Figure 13 Global Respiratory drug delivery formulations Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 14 “V” Shaped Recovery: Global Respiratory drug delivery formulations Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 15 “U” Shaped Recovery: Global Respiratory drug delivery formulations Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 16 “W” Shaped Recovery: Global Respiratory drug delivery formulations Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 17 “L” Shaped Recovery: Global Respiratory drug delivery formulations Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 18 Global Respiratory Drug Delivery Devices Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 19 “V” Shaped Recovery: Global Respiratory Drug Delivery Devices Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 20 “U” Shaped Recovery: Global Respiratory Drug Delivery Devices Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 21 “W” Shaped Recovery: GlobalRespiratory Drug Delivery Devices Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 22 “L” Shaped Recovery: GlobalRespiratory Drug Delivery Devices Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 23 Global Respiratory Drug Delivery Formulation Market Share Forecast by Type, 2021, 2026, 2032 (%)
Figure 24 Global Respiratory Drug Delivery Formulation Market for Dry Powder Formulation Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 25 Global Respiratory Drug Delivery Formulation Market for Dry Powder Formulation Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 26 Global Respiratory Drug Delivery Formulation Market for Dry Powder Formulation Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 27 Global Respiratory Drug Delivery Formulation Market for Dry Powder Formulation Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 28 Global Respiratory Drug Delivery Formulation Market for Dry Powder Formulation Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 29 Global Respiratory Drug Delivery Formulation Market for Suspension Aerosol Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 30 Global Respiratory Drug Delivery Formulation Market for Suspension Aerosol Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 31 Global Respiratory Drug Delivery Formulation Market for Suspension Aerosol Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 32 Global Respiratory Drug Delivery Formulation Market for Suspension Aerosol Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 33 Global Respiratory Drug Delivery Formulation Market for Suspension Aerosol Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 34 Global Respiratory Drug Delivery Formulation Market for Solution Aerosol Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 35 Global Respiratory Drug Delivery Formulation Market for Solution Aerosol Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 36 Global Respiratory Drug Delivery Formulation Market for Solution Aerosol Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 37 Global Respiratory Drug Delivery Formulation Market for Solution Aerosol Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 38 Global Respiratory Drug Delivery Formulation Market for Solution Aerosol Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 39 Global Respiratory Drug Delivery Formulation Market Share Forecast by Type, 2021, 2026, 2032(%)
Figure 40 Global Respiratory Drug Delivery Formulation Market for Metered Dose Inhalers (MDIS) Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 41 Global Respiratory Drug Delivery Formulation Market for Metered Dose Inhalers (MDIS) Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 42 Global Respiratory Drug Delivery Formulation Market for Metered Dose Inhalers (MDIS) Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 43 Global Respiratory Drug Delivery Formulation Market for Metered Dose Inhalers (MDIS) Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 44 Global Respiratory Drug Delivery Formulation Market for Metered Dose Inhalers (MDIS) Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 45 Global Respiratory Drug Delivery Formulation Market for Dry Powder Inhalers (DPIS) Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 46 Global Respiratory Drug Delivery Formulation Market for Dry Powder Inhalers (DPIS) Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 47 Global Respiratory Drug Delivery Formulation Market for Dry Powder Inhalers (DPIS) Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 48 Global Respiratory Drug Delivery Formulation Market for Dry Powder Inhalers (DPIS) Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 49 Global Respiratory Drug Delivery Formulation Market for Dry Powder Inhalers (DPIS) Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 50 Global Respiratory Drug Delivery Formulation Market for Nebulizers Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 51 Global Respiratory Drug Delivery Formulation Market for Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 52 Global Respiratory Drug Delivery Formulation Market for Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 53 Global Respiratory Drug Delivery Formulation Market for Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 54 Global Respiratory Drug Delivery Formulation Market for Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 55 Global Respiratory Drug Delivery Formulation Market for Others Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 56 Global Respiratory Drug Delivery Formulation Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 57 Global Respiratory Drug Delivery Formulation Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 58 Global Respiratory Drug Delivery Formulation Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 59 Global Respiratory Drug Delivery Formulation Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 60 Global Respiratory Nebulizers Market Share Forecast by Type, (%)
Figure 61 Global Respiratory Nebulizers Market for Soft Mist Nebulizers Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 62 Global Respiratory Nebulizers Market for Soft Mist Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 63 Global Respiratory Nebulizers Market for Soft Mist Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 64 Global Respiratory Nebulizers Market for Soft Mist Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 65 Global Respiratory Nebulizers Market for Soft Mist Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 66 Global Respiratory Nebulizers Market for Jet Nebulizers Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 67 Global Respiratory Nebulizers Market for Jet Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 68 Global Respiratory Nebulizers Market for Jet Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 69 Global Respiratory Nebulizers Market for Jet Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 70 Global Respiratory Nebulizers Market for Jet Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 71 Global Respiratory Nebulizers Market for Ultrasonic Nebulizers Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 72 Global Respiratory Nebulizers Market for Ultrasonic Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 73 Global Respiratory Nebulizers Market for Ultrasonic Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 74 Global Respiratory Nebulizers Market for Ultrasonic Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 75 Global Respiratory Nebulizers Market for Ultrasonic Nebulizers Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 76 Global Plain Canisters Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 77 “V” Shaped Recovery: Global Plain Canisters Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 78 “U” Shaped Recovery: Global Plain Canisters Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 79 “W” Shaped Recovery: Global Plain Canisters Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 80 “L” Shaped Recovery: Global Plain Canisters Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 81 Global Coated Canister Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 82 “V” Shaped Recovery: Global Coated Canister Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 83 “U” Shaped Recovery: GlobalCoated Canister Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 84 “W” Shaped Recovery: GlobalCoated Canister Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 85 “L” Shaped Recovery: Global Coated Canister Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 86 Global Respiratory Drug Delivery Technologies Market Share Forecast by Application, 2021, 2026, 2032(%)
Figure 87 Global Asthma Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 88 “V” Shaped Recovery: Global Asthma Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 89 “U” Shaped Recovery: Global Asthma Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 90 “W” Shaped Recovery: Global Asthma Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 91 “L” Shaped Recovery: Global Asthma Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 92 Global COPD Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 93 “V” Shaped Recovery: Global COPD Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 94 “U” Shaped Recovery: Global COPD Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 95 “W” Shaped Recovery: Global COPD Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 96 “L” Shaped Recovery: Global COPD Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 97 Global Cystic Fibrosis Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 98 “V” Shaped Recovery: Global Cystic Fibrosis Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 99 “U” Shaped Recovery: Global Cystic Fibrosis Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 100 “W” Shaped Recovery: Global Cystic Fibrosis Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 101 “L” Shaped Recovery: Global Cystic Fibrosis Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 102 Global Others Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 103 “V” Shaped Recovery: Global Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 104 “U” Shaped Recovery: Global Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 105 “W” Shaped Recovery: Global Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 106 “L” Shaped Recovery: Global Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 107 Global Respiratory Drug Delivery Technologies Market Share Forecast by End-User, 2021, 2026, 2032(%)
Figure 108 Global Respiratory Drug Delivery Technologies Market for Homecare Settings Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 109 Global Respiratory Drug Delivery Technologies Market for Homecare Settings Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 110 Global Respiratory Drug Delivery Technologies Market for Homecare Settings Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 111 Global Respiratory Drug Delivery Technologies Market for Homecare Settings Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 112 Global Respiratory Drug Delivery Technologies Market for Homecare Settings Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 113 Global Respiratory Drug Delivery Technologies Market for Hospitals & Clinics Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 114 Global Respiratory Drug Delivery Technologies Market for Hospitals & Clinics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 115 Global Respiratory Drug Delivery Technologies Market for Hospitals & Clinics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 116 Global Respiratory Drug Delivery Technologies Market for Hospitals & Clinics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 117 Global Respiratory Drug Delivery Technologies Market for Hospitals & Clinics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 118 Global Respiratory Drug Delivery Technologies Market for Others Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 119 Global Respiratory Drug Delivery Technologies Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 120 Global Respiratory Drug Delivery Technologies Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 121 Global Respiratory Drug Delivery Technologies Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 122 Global Respiratory Drug Delivery Technologies Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 123 Global Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion)
Figure 124 Global Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion): “V” Shaped Recovery
Figure 125 Global Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion): “U” Shaped Recovery
Figure 126 Global Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 127 Global Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 128 North America Respiratory Drug Delivery Technologies Market Forecast 2022-2032 (US$ billion, AGR %)
Figure 129 North America Respiratory Drug Delivery Technologies Market Forecast by Country 2022-2032 (US$ billion)
Figure 130 North America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion)
Figure 131 North America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 132 North America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 133 North America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 134 North America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 135 North America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion)
Figure 136 North America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 137 North America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 138 North America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 139 North America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 140 North America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 141 North America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 142 North America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 143 North America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 144 North America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 145 North America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion)
Figure 146 North America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 147 North America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "U” Shaped Recovery
Figure 148 North America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 149 North America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 150 North America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 151 North America Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 152 North America Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 153 North America Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 154 North America Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 155 North America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 156 North America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 157 North America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 158 North America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 159 North America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 160 North America Respiratory Drug Delivery Devices Market Forecast by End User, 2022-2032 (US$ billion)
Figure 161 North America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 162 North America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 163 North America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 164 North America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 165 U.S. Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 166 U.S. Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 167 U.S. Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 168 U.S. Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 169 U.S. Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 170 Canada Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 171 Canada Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 172 Canada Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 173 Canada Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 174 Canada Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 175 Europe Respiratory Drug Delivery Technologies Market Forecast 2022-2032 (US$ billion, AGR%)
Figure 176 Europe Respiratory Drug Delivery Technologies Market Forecast by Country 2022-2032 (US$ billion)
Figure 177 Europe Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion)
Figure 178 Europe Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 179 Europe Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 180 Europe Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 181 Europe Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 182 Europe Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion)
Figure 183 Europe Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 184 Europe Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 185 Europe Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 186 Europe Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 187 Europe Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 188 Europe Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 189 Europe Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 190 Europe Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 191 Europe Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 192 Europe Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion)
Figure 193 Europe Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 194 Europe Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "U” Shaped Recovery
Figure 195 Europe Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 196 Europe Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 197 Europe Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 198 Europe Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 199 Europe Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 200 Europe Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 201 Europe Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 202 Europe Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 203 Europe Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 204 Europe Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 205 Europe Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 206 Europe Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 207 Europe Respiratory Drug Delivery Devices Market Forecast by End User, 2022-2032 (US$ billion)
Figure 208 Europe Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 209 Europe Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 210 Europe Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 211 Europe Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 212 Germany Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 213 Germany Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 214 Germany Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 215 Germany Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 216 Germany Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 217 UK Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 218 UK Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 219 UK Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 220 UK Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 221 UK Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 222 France Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 223 France Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 224 France Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 225 France Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 226 France Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 227 Italy Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 228 Italy Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 229 Italy Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 230 Italy Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 231 Italy Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 232 Spain Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 233 Spain Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 234 Spain Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 235 Spain Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 236 Spain Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 237 Russia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 238 Russia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 239 Russia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 240 Russia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 241 Russia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 242 Rest of Europe Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 243 Rest of Europe Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 244 Rest of Europe Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 245 Rest of Europe Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 246 Rest of Europe Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 247 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast 2022-2032 (US$ billion, AGR %)
Figure 248 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Country 2022-2032 (US$ billion)
Figure 249 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion)
Figure 250 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 251 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 252 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 253 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 254 Asia Pacific Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion)
Figure 255 Asia Pacific Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 256 Asia Pacific Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 257 Asia Pacific Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 258 Asia Pacific Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 259 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 260 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 261 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 262 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 263 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 264 Asia Pacific Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion)
Figure 265 Asia Pacific Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 266 Asia Pacific Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "U” Shaped Recovery
Figure 267 Asia Pacific Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 268 Asia Pacific Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 269 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 270 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 271 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 272 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 273 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 274 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 275 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 276 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 277 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 278 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 279 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by End User, 2022-2032 (US$ billion)
Figure 280 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 281 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 282 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 283 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 284 Japan Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 285 Japan Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 286 Japan Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 287 Japan Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 288 Japan Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 289 China Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 290 China Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 291 China Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 292 China Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 293 China Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 294 India Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 295 India Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 296 India Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 297 India Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 298 India Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 299 Australia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 300 Australia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 301 Australia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 302 Australia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 303 Australia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 304 South Korea Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 305 South Korea Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 306 South Korea Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 307 South Korea Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 308 South Korea Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 309 Rest of Asia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 310 Rest of Asia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 311 Rest of Asia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 312 Rest of Asia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 313 Rest of Asia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 314 Latin America Respiratory Drug Delivery Technologies Market Forecast 2022-2032 (US$ billion, AGR%)
Figure 315 Latin America Respiratory Drug Delivery Technologies Market Forecast by Country 2022-2032 (US$ billion)
Figure 316 Latin America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion)
Figure 317 Latin America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 318 Latin America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 319 Latin America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 320 Latin America Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 321 Latin America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion)
Figure 322 Latin America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 323 Latin America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 324 Latin America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 325 Latin America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 326 Latin America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 327 Latin America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 328 Latin America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 329 Latin America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 330 Latin America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 331 Latin America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion)
Figure 332 Latin America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 333 Latin America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "U” Shaped Recovery
Figure 334 Latin America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 335 Latin America Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 336 Latin America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 337 Latin America Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 338 Latin America Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 339 Latin America Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 340 Latin America Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 341 Latin America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 342 Latin America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 343 Latin America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 344 Latin America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 345 Latin America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 346 Latin America Respiratory Drug Delivery Devices Market Forecast by End User, 2022-2032 (US$ billion)
Figure 347 Latin America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 348 Latin America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 349 Latin America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 350 Latin America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 351 Brazil Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 352 Brazil Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 353 Brazil Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 354 Brazil Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 355 Brazil Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 356 Mexico Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 357 Mexico Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 358 Mexico Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 359 Mexico Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 360 Mexico Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 361 Rest of Latin America Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 362 Rest of Latin America Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 363 Rest of Latin America Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 364 Rest of Latin America Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 365 Rest of Latin America Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 366 MEA Respiratory Drug Delivery Technologies Market Forecast 2022-2032 (US$ billion, AGR%)
Figure 367 MEA Respiratory Drug Delivery Technologies Market Forecast by Country 2022-2032 (US$ billion)
Figure 368 MEA Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion)
Figure 369 MEA Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 370 MEA Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 371 MEA Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 372 MEA Respiratory Drug Delivery Technologies Market Forecast by Product, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 373 MEA Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion)
Figure 374 MEA Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 375 MEA Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 376 MEA Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 377 MEA Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 378 MEA Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 379 MEA Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 380 MEA Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 381 MEA Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 382 MEA Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 383 MEA Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion)
Figure 384 MEA Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 385 MEA Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "U” Shaped Recovery
Figure 386 MEA Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 387 MEA Respiratory Nebulizers Market Forecast by Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 388 MEA Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 389 MEA Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 390 MEA Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 391 MEA Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 392 MEA Respiratory Drug Delivery Technologies Market Forecast by Canister Type, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 393 MEA Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ billion)
Figure 394 MEA Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 395 MEA Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 396 MEA Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 397 MEA Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 398 MEA Respiratory Drug Delivery Devices Market Forecast by End User, 2022-2032 (US$ billion)
Figure 399 MEA Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "V" Shaped Recovery
Figure 400 MEA Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "U" Shaped Recovery
Figure 401 MEA Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "W" Shaped Recovery
Figure 402 MEA Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032 (US$ billion): "L" Shaped Recovery
Figure 403 South Africa Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 404 South Africa Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 405 South Africa Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 406 South Africa Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 407 South Africa Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 408 GCC Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 409 GCC Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 410 GCC Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 411 GCC Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 412 GCC Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 413 Rest of MEA Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 414 Rest of MEA Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 415 Rest of MEA Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 416 Rest of MEA Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 417 Rest of MEA Respiratory Drug Delivery Technologies Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 418 Respiratory Drug Delivery Technologies Market: Company Share Analysis, 2021
Figure 419 GSK Corporation: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 420 GSK Corporation: Regional Revenue Shares, 2021
Figure 421 GSK: Segmental Revenue Shares, 2021
Figure 422 Philips Respironics: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 423 Philips Respironics: Regional Revenue Shares, 2021
Figure 424 Philips Respironics: Segmental Revenue Shares, 2021
Figure 425 Boehringer Ingelheim GmbH: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 426 Boehringer Ingelheim GmbH: Regional Revenue Shares, 2021
Figure 430 AstraZeneca Plc: Net Revenue, 2017-2021 (US$ billion, AGR%)
Figure 431 AstraZeneca Plc: Regional Revenue Shares, 2021
Figure 432 AstraZeneca Plc: Segmental Revenue Shares, 2021
Figure 433 Merck & Co., Inc.: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 434 Merck & Co., Inc.: Regional Revenue Shares, 2021
Figure 435 Merck & Co., Inc.: Segmental Revenue Shares, 2021
Figure 436 Novartis AG: Net Revenue, 2017-2021 (US$ billion, AGR%)
Figure 437 Novartis AG: Regional Revenue Shares, 2021
Figure 438 Novartis AG: Segmental Revenue Shares, 2021
Figure 442 Sunovion pharmaceuticals: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 443 Sunovion pharmaceuticals: Regional Revenue Shares, 2021
Figure 453 Global Respiratory Drug Delivery Technologies Market Share Forecast by Product, 2021, 2027, 2032(%)
Figure 454 Global Respiratory Drug Delivery Technologies Market Share Forecast by Region, 2021, 2026, 2032(%)
ページTOPに戻る
Summary
この調査レポートは世界の呼吸器系薬物送達技術市場を調査し、製品別、タイプ別、製品タイプ別、ネブライザータイプ別、キャニスタータイプ別、用途別、エンドユーザー別、地域別に2022年から2032年までの予測結果を掲載しています。また関連企業情報を提供しています。
主な掲載内容(目次より抜粋)
-
レポート概要
-
エグゼクティブサマリー
-
市場のダイナミックス
-
世界の呼吸器系薬物送達技術市場
-
世界の呼吸器系薬物送達技術市場規模予測、製品別、2022-2032年
-
呼吸器用薬物送達製剤市場予測、タイプ別、2022-2032年
-
呼吸器用薬物送達デバイス市場市場予測、タイプ別、2022-2032年
-
呼吸用ネブライザー市場予測、タイプ別、2022-2032年
-
世界の呼吸器用薬物送達技術市場予測、キャニスタータイプ別、2022-2032年
-
世界の呼吸器系薬物送達技術市場規模予測、用途別、2022-2032年
-
呼吸器系薬物送達技術市場予測、エンドユーザー別、2022-2032年
-
呼吸器系薬物送達技術の全米市場予測、2022-2032年
-
北米の呼吸器系薬物送達技術市場、2022-2032年
-
欧州の呼吸器系薬物送達技術市場、2022-2032年
-
アジア太平洋地域の呼吸器系薬物送達技術市場、2022-2032年
-
ラテンアメリカの呼吸器系薬物送達技術市場、2022-2032年
-
MEAの呼吸器系薬物送達技術市場、2022-2032年
-
企業プロファイル:呼吸器系薬物送達技術市場
Report Details
The Respiratory Drug Delivery Technologies Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
The Rise in Prevalence of Respiratory Diseases, Technological Advancements, And Outbreak of COVID-19 Pandemic Are Driving the Market Growth
Some of the major forces propelling the global respiratory drug delivery technologies market include an increase in prevalence and incidence of respiratory diseases, technological advancements in respiratory drug delivery, and the outbreak of the Covid-19 pandemic. Furthermore, the use of nanoparticles and polymeric carriers in respiratory drug delivery systems is expected to propel the overall market. Some trends in the field are indicated by recent advances in inhaled devices and formulations. High-dose dry powder alternatives are becoming increasingly popular with nebulized formulations and would be supported by the development of new high-dose (> 100 mg) DPI (Dry Powder Inhalers) variants. Single-use disposable dry powder inhalers can be helpful in the treatment of various respiratory diseases including infectious diseases.
Nebulizers, particularly software-aided systems using smart cards and an electronic control unit that can accurately direct lung deposition and total dosage, will play a crucial role in novel cancer therapies and improve the reliability of inhaled therapy clinical trials. A greater proportion of future formulations of aerosols is also expected to involve repurposed drugs.
The use of nanoparticles in pulmonary drug delivery formulations for DPI (Dry Powder Inhalers) remains a hot topic. Nanoparticles of the same drug were found to have significantly less impact on the oropharyngeal region and higher peripheral deposition in humans compared to micronized salbutamol sulfate, suggesting greater local bioavailability for a sustained period of time due to their smaller size.
Barriers of Respiratory Drugs Delivery
The respiratory system has evolved self-defence methods to keep inhaled medication particles out of the lungs and to eliminate or inactivate them once established and hence pulmonary drug administration is relatively difficult. In addition to mechanical, pharmacological, and immunological barriers, behavioural barriers such as compliance and inhaler technique have a negative impact on pulmonary medication delivery. Strategies for mitigating the effects of these barriers include the use of inhaler devices and compositions that efficiently deliver medicine to the lungs, adequate inhaler technique, and increased patient education. If respiratory drug delivery devices are used appropriately, the pulmonary route offers enormous opportunities, often meeting unmet clinical requirements.
What Questions Should You Ask before Buying a Market Research Report?
• How is the respiratory drug delivery technologies market evolving?
• What is driving and restraining the respiratory drug delivery technologies market?
• How will each respiratory drug delivery technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each respiratory drug delivery technologies submarket develop from 2022 to 2032?
• What will be the main drivers for the overall market from 2022 to 2032?
• Will leading respiratory drug delivery technologies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the respiratory drug delivery technologies projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What are the implications of respiratory drug delivery technologies projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the respiratory drug delivery technologies market?
• Where is the respiratory drug delivery technologies market heading? And how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and? C-suite?
You need to discover how this will impact the respiratory drug delivery technologies market today, and over the next 10 years:
• Our 587-page report provides 456 tables and 454 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the respiratory drug delivery technologies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
The report delivers exclusive COVID-19 variations and economic data specific to your market.
Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising respiratory drug delivery technologies prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
By Product
• Formulations
• Devices
By Type
• Dry Powder
• Suspension Aerosol
• Solution Aerosol
By Product Type
• Metered Dose Inhalers (MDIS)
• Dry Powder Inhalers (DPIS)
• Nebulizers and Accessories
By Nebulizers Type
• Soft Mist Nebulizers
• Jet Nebulizers
• Ultrasonic Nebulizers
By Canister Type
• Plain Canisters
• Coated Canister
By Application
• Asthma
• COPD
• Cystic Fibrosis
• Others
By End User
• Homecare
• Hospitals & Clinics
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 21 leading national markets:
North America
• U.S.
• Canada
• Mexico
Europe
• Germany
• Spain
• United Kingdom
• France
• Italy
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Respiratory Drug Delivery Technologies Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies
• AptarGroup, Inc.
• AstraZeneca plc.
• Boehringer Ingelheim GmbH
• Cipla Limited
• Graham Field Health Products
• GSK Corporation
• Medisana GmbH.
• Merck & Co., Inc.
• Novartis AG
• Omron Corporation
• Philips Respironics
• Recipharm Ab.
• Sunovion Pharmaceuticals Inc.
• Teva Pharmaceuticals
• 3M Healthcare
Overall world revenue for Respiratory Drug Delivery Technologies Market, 2022 to 2032 in terms of value the market will surpass US$59.51 billion in 2022, our work calculates. We predict strong revenue growth through 2032. Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Respiratory Drug Delivery Technologies Market, 2022 to 2032 Market report help you?
In summary, our 580+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Respiratory Drug Delivery Technologies Market, 2022 to 2032 Market, with forecasts, type company size each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2032 for 5 regional and 21 key national markets – See forecasts for the Respiratory Drug Delivery Technologies Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 15 of the major companies involved in the Respiratory Drug Delivery Technologies Market, 2022 to 2032.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Respiratory Drug Delivery Technologies Market, 2022 to 2032 market leading companies. You will find data, trends and predictions.
ページTOPに戻る
Table of Contents
Table of Contents
1. Report Overview
1.1 Introduction to Respiratory Drug Delivery Technologies Market
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered By This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.6.3 Market Evaluation &Forecast Methodology
1.7 Frequently Asked Questions (FAQs)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers for Respiratory Drug Delivery Technologies Market
3.1.1 Increase in Prevalence and Incidence of Respiratory Diseases is driving the Market
3.1.2 Technological Advancements in Respiratory Drug Delivery Expected to boost the Market
3.1.3 Outbreak of COVID-19 Pandemic
3.1.4 Growing Support of Government and NGOs for Respiratory Diseases Healthcare Awareness
3.1.5 Launch of Smart/Digital Inhalers will Propel the Adoption of Advanced Drug Delivery Devices
3.2 Restraints for Respiratory Drug Delivery Technologies Market
3.2.1 Stringent Government Regulations is Expected to Hinder the Market Growth
3.2.2 Intense Competition Among Vendors is Projected to Restrain the Market Growth
3.3 Opportunities for Respiratory Drug Delivery Technologies Market
3.3.1 Trends in Metered Dose Inhaler (MDI) Technology is Expected to propel the Market in Near Future
3.3.2 Mergers, Agreements, and Acquisitions by the Market Players is a Major Trend Witnessed in the Market
3.3.3 Dry Powder Drug Delivery Product Innovation Driving the Adoption of Respiratory Drugs
3.4 Challenges for Respiratory Drug Delivery Technologies Market
3.4.1 Pricing Pressure a Major Challenge
3.4.2 Challenges Associated with Respiratory Drugs Delivery Design
3.4.3 Barriers for Respiratory Drugs Delivery
3.5 SWOT Analysis for Respiratory Drug Delivery Technologies Market
3.5.1 Strengths
3.5.1.1 Rising Need for Effective Drugs’ Absorption and Convenient Self-Administration Emphasizes the Importance of the R&D Investment
3.5.2 Weakness
3.5.2.1 Financial Loss Due To Innovative Drug Delivery Technology Failure Has Been a Major Problem
3.5.3 Opportunities:
3.5.3.1 Increase in Number of Collaborations between Biopharmaceutical Companies
3.5.4 Threats: Drug Delivery Technologies Market
3.5.4.1 Supply Chain Disruption of Respiratory Drugs is the Biggest Threat to the Respiratory Drug Delivery Market
3.6 Porter’s Five Forces Analysis: Respiratory Drug Delivery Technologies Market
3.6.1 Bargaining Power of Supplier: High
3.6.2 Threat of New Entrants: Moderate
3.6.3 Bargaining Power of Buyer: Moderate
3.6.4 Competitive Rivalry: High
3.6.5 Threat of Substitutes: Moderate
3.7 PEST Analysis: Respiratory Drug Delivery Technologies Market
3.7.1 Political Factors Impacting Respiratory Drug Delivery Technologies Market
3.7.2 Economic Factors Impacting Respiratory Drug Delivery Technologies Market
3.7.3 Social Factors Impacting Respiratory Drug Delivery Technologies Market
3.7.4 Technological Factors Impacting Respiratory Drug Delivery Technologies Market
4 Global Respiratory Drug Delivery Technologies Market
4.1 Global Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
4.2 COVID-19 Impact Overview
4.3 "V" shaped Recovery - Rapid Decline - Sharp Borrow -Rapid Recovery
4.4 "U" Shaped Recovery -Rapid Decline Early Then Slow - Gradual at the Bottom - Slow Recovery at First - Faster Recovery Later On
4.5 "W" Shaped Recovery -Rapid Decline - Rapid Recovery- Return of Virus - Another Sharp Decline -Recovery
4.6 "L" Shaped Recovery - Rapid Decline - Then Slow Growth
5 Global Respiratory Drug Delivery Technologies, by Product, Market Size Forecast 2022-2032
5.1 Global Respiratory Drug Delivery Formulations Segment: Revenue Forecast 2022-2032
5.1.1 Increasing Demand For Efficient Drug Formulations Will Boost Market Growth
5.1.2 Recovery Forecasts (V, U, W, L)
5.2 Global Respiratory Drug Delivery Devices Segment: Revenue Forecast 2022-2032
5.2.1 Respiratory Drug Delivery Devices Account for Largest Revenue Segment
5.2.2 Recovery Forecasts (V, U, W, L)
6 Respiratory Drug Delivery Formulation Market by Type Forecast, 2022-2032
6.1 Dry Powder Formulation Segment Market Forecast, 2022-2032
6.1.1 Dry Powder Inhalation Is Far More Convenient Than Traditional Oral Medication
6.1.2 Recovery Scenarios (V, U, W, L)
6.2 Suspension Aerosol Segment Market Forecast, 2022-2032
6.2.1 Most Widely Used Inhalation Medicines Are Bronchodilators And Corticosteroids.
6.2.2 Recovery Scenarios (V, U, W, L)
6.3 Solution Aerosol Segment Market Forecast, 2022-2032
6.3.1 Growing Demand For Advanced Therapies To Manage Asthma And Other Respiratory Diseases
6.3.2 Recovery Scenarios (V, U, W, L)
7 Respiratory Drug Delivery Devices Market, by Type, Market Forecast, 2022-2032
7.1 Metered Dose Inhalers (MDIs) Segment Market Forecast, 2022-2032
7.1.1 Metered Dose Inhaler (MDIs) Is An Automated System Designed To Provide Fine Mist Of Medication
7.1.2 Recovery Scenarios (V, U, W, L)
7.2 Dry Powder Inhalers (DPIs) Segment Market Forecast, 2022-2032
7.2.1 Advantages Of DPIs Over Other Inhalers Is Expected To Propel Its Adoption
7.2.2 Recovery Scenarios (V, U, W, L)
7.3 Nebulizers Segment Market Forecast, 2022-2032
7.3.1 Nebulizers Are Particularly Useful For Diseases Such As Cystic Fibrosis And COPD Requiring High Pulmonary Doses
7.3.2 Recovery Scenarios (V, U, W, L)
7.4 Others Segment Market Forecast, 2022-2032
7.4.1 Frequent Demand For Accessories Is Expected To Propel The Segment Growth
7.4.2 Recovery Scenarios (V, U, W, L)
8 Respiratory Nebulizers Market by Type Forecast, 2022-2032
8.1 Soft Mist Nebulizers Segment Market Forecast, 2022-2032
8.1.1 Increasing Demand For Portable Devices To Boost Market Growth
8.1.2 Recovery Scenarios (V, U, W, L)
8.2 Jet Nebulizers Segment Market Forecast, 2022-2032
8.2.1 Increasing Adoption In Paediatric Population Is Expected To Propel Market Growth
8.2.2 Recovery Scenarios (V, U, W, L)
8.3 Ultrasonic Nebulizers Segment Market Forecast, 2022-2032
8.3.1 Presence Of Wide Portfolio Of Products By Localized Players
8.3.2 Recovery Scenarios (V, U, W, L)
9 Global Respiratory Drug Delivery Technologies Market Forecast, By Canister Type, 2022-2032
9.1 Plain Canisters Segment: Revenue Forecast 2022-2032
9.1.1 Plain Canisters Grabbed the Largest Market Share
9.1.2 Recovery Forecasts (V, U, W, L)
9.2 Coated Canister Segment: Revenue Forecast 2022-2032
9.2.1 Coated Canister Are In High Demand Owing To Their Ability To Maintain The Composition Of Drug Content
9.2.2 Recovery Forecasts (V, U, W, L)
10 Global Respiratory Drug Delivery Technologies Market Size Forecast By Application, 2022-2032
10.1 Asthma Segment: Revenue Forecast 2022-2032
10.1.1 Rising Prevalence of Asthma Is Driving the Segment Growth
10.1.2 Recovery Forecasts (V, U, W, L)
10.2 COPD Segment: Revenue Forecast 2022-2032
10.2.1 Growing Awareness of COPD Driving Market Growth
10.2.2 Recovery Forecasts (V, U, W, L)
10.3 Cystic Fibrosis Segment: Revenue Forecast 2022-2032
10.3.1 Cystic Fibrosis Is A Common Genetic Disease In The United States White Population
10.3.2 Recovery Forecasts (V, U, W, L)
10.4 Others Segment: Revenue Forecast 2022-2032
10.4.1 Growing Allied Applications of Advanced Respiratory Drugs to Boost Growth of Others Segment
10.4.2 Recovery Forecasts (V, U, W, L)
11 Respiratory Drug Delivery Technologies Market by End-User Forecast, 2022-2032
11.1 Homecare Settings Segment Market Forecast, 2022-2032
11.1.1 Increased Adoption Owing To Covid Pandemic
11.1.2 Recovery Scenarios (V, U, W, L)
11.2 Hospitals & Clinics Segment Market Forecast, 2022-2032
11.2.1 Second-Largest Revenue Generating Segment
11.2.2 Recovery Scenarios (V, U, W, L)
11.3 Others Segment Market Forecast, 2022-2032
11.3.1 Rise In Demand For Rescue Inhalation Devices
11.3.2 Recovery Scenarios (V, U, W, L)
12 National Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
12.1 Global Respiratory Drug Delivery Technologies Market by Region Forecast 2022-2032
12.1 Recovery Scenarios (V, U, W, L)
13 North America Respiratory Drug Delivery Technologies Market, 2022-2032
13.1 North America is the Largest Revenue Grossing Region in the Global Market
13.2 North America Respiratory Drug Delivery Technologies Market by Country, Forecast 2022-2032
13.3 North America Respiratory Drug Delivery Technologies Market Forecast by Product
13.3.1 Recovery Scenarios (V, U, W, L): North America Respiratory Drug Delivery Technologies Market Forecast by Study Type, 2022-2032
13.4 North America Respiratory Drug Delivery Formulation Market Forecast by Type
13.4.1 Recovery Scenarios (V, U, W, L): North America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032
13.5 North America Respiratory Drug Delivery Devices Market Forecast by Type
13.5.1 Recovery Scenarios (V, U, W, L): North America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032
13.6 North America Respiratory Nebulizers Market Forecast by Type
13.6.1 Recovery Scenarios (V, U, W, L): North America Respiratory Nebulizers Market Forecast by Type, 2022-2032
13.7 North America Respiratory Drug Delivery Devices Market Forecast by Canister Type
13.7.1 Recovery Scenarios (V, U, W, L): North America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032
13.8 North America Respiratory Drug Delivery Devices Market Forecast by Application
13.8.1 Recovery Scenarios (V, U, W, L): North America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032
13.9 North America Respiratory Drug Delivery Devices Market Forecast by End-User
13.9.1 Recovery Scenarios (V, U, W, L): North America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032
13.10 U.S. Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
13.10.1 Presence of Leading Players is a major factor driving the U.S. Respiratory Drug Delivery Technologies Market
13.10.2 Growing R&D Expenditure and Outsourcing Activities
13.10.3 Recovery Scenarios (V, U, W, L): U.S. Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
13.11 Canada Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
13.11.1 Canada Market Anticipated To Witness the Fastest Growth in the North America Region
13.11.2 Growing Canadian Research and development initiatives for the advancement of drug delivery technology to accelerate growth
13.11.3 Recovery Scenarios (V, U, W, L): Canada Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
14 Europe Respiratory Drug Delivery Technologies Market, 2022-2032
14.1 Second Largest Revenue Grossing Region in the Global Market
14.2 Europe Respiratory Drug Delivery Technologies Market by Country, Forecast 2022-2032
14.3 Europe Respiratory Drug Delivery Technologies Market Forecast by Product
14.3.1 Recovery Scenarios (V, U, W, L): Europe Respiratory Drug Delivery Technologies Market Forecast by Study Type, 2022-2032
14.4 Europe Respiratory Drug Delivery Formulation Market Forecast by Type
14.4.1 Recovery Scenarios (V, U, W, L): Europe Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032
14.5 Europe Respiratory Drug Delivery Devices Market Forecast by Type
14.5.1 Recovery Scenarios (V, U, W, L): Europe Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032
14.6 Europe Respiratory Nebulizers Market Forecast by Type
14.6.1 Recovery Scenarios (V, U, W, L): Europe Respiratory Nebulizers Market Forecast by Type, 2022-2032
14.7 Europe Respiratory Drug Delivery Devices Market Forecast by Canister Type
14.7.1 Recovery Scenarios (V, U, W, L): Europe Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032
14.8 Europe Respiratory Drug Delivery Devices Market Forecast by Application
14.8.1 Recovery Scenarios (V, U, W, L): Europe Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032
14.9 Europe Respiratory Drug Delivery Devices Market Forecast by End-User
14.9.1 Recovery Scenarios (V, U, W, L): Europe Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032
14.10 Germany Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
14.10.1 Germany Is Home to a Few of the Biggest Pharmaceutical and Medical Device Firms of the World
14.10.2 Germany Is Positioned Strategically in the Pharmaceuticals Sector with an Established Healthcare System
14.10.3 Recovery Scenarios (V, U, W, L): Germany Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
14.11 UK Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
14.11.1 Presence of Well-Developed R&D Infrastructure
14.11.2 The UK has been a Hub for Inhalation Drugs And Drug Delivery System Production and Development
14.11.3 Recovery Scenarios (V, U, W, L): UK Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
14.12 France Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
14.12.1 Rising Preference for France for Drug R&D and Manufacturing by Leading Players
14.12.2 Growing Demand for Advanced Healthcare Services
14.12.3 Recovery Scenarios (V, U, W, L): France Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
14.13 Italy Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
14.13.1 Pharmaceutical Manufacturing Hub
14.13.2 Italian Respiratory Drug Delivery Technologies Market Is the Fourth Biggest Market within the European Region
14.13.3 Recovery Scenarios (V, U, W, L): Italy Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
14.14 Spain Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
14.14.1 Demand for Drugs Is Influenced By the Growth of the Pharmaceutical Industry
14.14.2 Spanish Economy Is Growing Strong
14.14.3 Recovery Scenarios (V, U, W, L): Spain Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
14.15 Russia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
14.15.1 Unmet Pharmaceutical Needs
14.15.2 Recovery Scenarios (V, U, W, L): Russia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
14.16 Rest of Europe Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
14.16.1 Increasing Prevalence of Chronic Diseases Drives the Market Growth in this Region
14.16.2 Recovery Scenarios (V, U, W, L): Rest of Europe Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
15 Asia Pacific Respiratory Drug Delivery Technologies Market, 2022-2032
15.1 Asia Pacific is the Fastest Growing Market
15.2 Asia Pacific Respiratory Drug Delivery Technologies Market by Country, Forecast 2022-2032
15.3 Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Product
15.3.1 Recovery Scenarios (V, U, W, L): Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Study Type, 2022-2032
15.4 Asia Pacific Respiratory Drug Delivery Formulation Market Forecast by Type
15.4.1 Recovery Scenarios (V, U, W, L): Asia Pacific Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032
15.5 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Type
15.5.1 Recovery Scenarios (V, U, W, L): Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032
15.6 Asia Pacific Respiratory Nebulizers Market Forecast by Type
15.6.1 Recovery Scenarios (V, U, W, L): Asia Pacific Respiratory Nebulizers Market Forecast by Type, 2022-2032
15.7 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Canister Type
15.7.1 Recovery Scenarios (V, U, W, L): Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032
15.8 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by Application
15.8.1 Recovery Scenarios (V, U, W, L): Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032
15.9 Asia Pacific Respiratory Drug Delivery Devices Market Forecast by End-User
15.9.1 Recovery Scenarios (V, U, W, L): Asia Pacific Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032
15.10 Japan Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
15.10.1 Japan Accounted For the Largest Market Share in the Asia Pacific Region
15.10.2 Increase in outsourcing drug development in Japan has propelled the Market Growth
15.10.3 Recovery Scenarios (V, U, W, L): Japan Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
15.11 China Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
15.11.1 Strategic Initiatives Undertaken by the Market Players
15.11.2 Increasing Healthcare Spending In China
15.11.3 Recovery Scenarios (V, U, W, L): China Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
15.12 India Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
15.12.1 Developing Healthcare Infrastructure
15.12.2 Government Support for Pharmaceutical Industry in India
15.12.3 Recovery Scenarios (V, U, W, L): India Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
15.13 Australia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
15.13.1 Australia Is Renowned For Conducting High-Standard R&D Activities
15.13.2 Availability Of High-End Healthcare Infrastructure
15.13.3 Recovery Scenarios (V, U, W, L): Australia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
15.14 South Korea Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
15.14.1 Increasing prevalence of respiratory disorders and presence of favourable government policies
15.14.2 Availability of skilled workforce and favourable R&D scenario
15.14.3 Recovery Scenarios (V, U, W, L): South Korea Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
15.15 Rest of Asia Pacific Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
15.15.1 Rising Disposable Income
15.15.2 Recovery Scenarios (V, U, W, L): Rest of Asia Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
16 Latin America Respiratory Drug Delivery Technologies Market, 2022-2032
16.1 Latin America Respiratory Drug Delivery Technologies Market
16.2 Latin America Respiratory Drug Delivery Technologies Market by Country, Forecast 2022-2032
16.3 Latin America Respiratory Drug Delivery Technologies Market Forecast by Product
16.3.1 Recovery Scenarios (V, U, W, L): Latin America Respiratory Drug Delivery Technologies Market Forecast by Study Type, 2022-2032
16.4 Latin America Respiratory Drug Delivery Formulation Market Forecast by Type
16.4.1 Recovery Scenarios (V, U, W, L): Latin America Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032
16.5 Latin America Respiratory Drug Delivery Devices Market Forecast by Type
16.5.1 Recovery Scenarios (V, U, W, L): Latin America Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032
16.6 Latin America Respiratory Nebulizers Market Forecast by Type
16.6.1 Recovery Scenarios (V, U, W, L): Latin America Respiratory Nebulizers Market Forecast by Type, 2022-2032
16.7 Latin America Respiratory Drug Delivery Devices Market Forecast by Canister Type
16.7.1 Recovery Scenarios (V, U, W, L): Latin America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032
16.8 Latin America Respiratory Drug Delivery Devices Market Forecast by Application
16.8.1 Recovery Scenarios (V, U, W, L): Latin America Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032
16.9 Latin America Respiratory Drug Delivery Devices Market Forecast by End-User
16.9.1 Recovery Scenarios (V, U, W, L): Latin America Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032
16.10 Brazil Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
16.10.1 Fastest-Growing Economy in Latin America
16.10.2 High Potential Manufacturing Environment
16.10.3 Recovery Scenarios (V, U, W, L): Brazil Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
16.11 Mexico Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
16.11.1 Lower Manufacturing Costs than In the U.S.
16.11.2 Presence of untapped market opportunity
16.11.3 Recovery Scenarios (V, U, W, L): Mexico Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
16.12 Rest of Latin America Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
16.12.1 Evolving Healthcare Infrastructure in Latin America
16.12.2 Recovery Scenarios (V, U, W, L): Rest of Latin America Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
17 MEA Respiratory Drug Delivery Technologies Market, 2022-2032
17.1 Rising Prevalence of Chronic respiratory diseases in MEA Region
17.2 MEA Respiratory Drug Delivery Technologies Market by Country, Forecast 2022-2032
17.3 MEA Respiratory Drug Delivery Technologies Market Forecast by Product
17.3.1 Recovery Scenarios (V, U, W, L): MEA Respiratory Drug Delivery Technologies Market Forecast by Study Type, 2022-2032
17.4 MEA Respiratory Drug Delivery Formulation Market Forecast by Type
17.4.1 Recovery Scenarios (V, U, W, L): MEA Respiratory Drug Delivery Formulation Market Forecast by Type, 2022-2032
17.5 MEA Respiratory Drug Delivery Devices Market Forecast by Type
17.5.1 Recovery Scenarios (V, U, W, L): MEA Respiratory Drug Delivery Devices Market Forecast by Type, 2022-2032
17.6 MEA Respiratory Nebulizers Market Forecast by Type
17.6.1 Recovery Scenarios (V, U, W, L): MEA Respiratory Nebulizers Market Forecast by Type, 2022-2032
17.7 MEA Respiratory Drug Delivery Devices Market Forecast by Canister Type
17.7.1 Recovery Scenarios (V, U, W, L): MEA Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032
17.8 MEA Respiratory Drug Delivery Devices Market Forecast by Application
17.8.1 Recovery Scenarios (V, U, W, L): MEA Respiratory Drug Delivery Technologies Market Forecast by Application, 2022-2032
17.9 MEA Respiratory Drug Delivery Devices Market Forecast by End-User
17.9.1 Recovery Scenarios (V, U, W, L): MEA Respiratory Drug Delivery Technologies Market Forecast by End-User, 2022-2032
17.10 South Africa Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
17.10.1 Prevalence of asthma in South Africa is Increasing Rapidly
17.10.2 Increased base of target population due to mining industry and presence of favourable initiatives
17.10.3 Recovery Scenarios (V, U, W, L): South Africa Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
17.11 GCC Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
17.11.1 Presence of Huge Growth Opportunities
17.11.2 Advances in personalized medicine and home healthcare have ushered in a paradigm change
17.11.3 Recovery Scenarios (V, U, W, L): GCC Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
17.12 Rest of MEA Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
17.12.1 Increased Respiratory Diseases Burden and Increasing investment from international companies
17.12.2 Extensive Tobacco Use Increases Incidence of Respiratory disorders
17.12.3 Recovery Scenarios (V, U, W, L): Rest of MEA Respiratory Drug Delivery Technologies Market Forecast, 2022-2032
18 Company Profiles: Respiratory Drug Delivery Technologies Market
18.1 Respiratory Drug Delivery Technologies Market: Company Share Analysis
18.2 Respiratory Drug Delivery Technologies Market Recent Developments, 2018-2022
18.3 GlaxoSmithKline PLC
18.3.1 Company Snapshot
18.3.2 Company Overview
18.3.3 Financial Analysis
18.3.3.1 Net Revenue, 2017-2021
18.3.3.2 Regional Revenue/Market Shares, 2021
18.3.3.3 Segmental Revenue/Market Shares, 2021
18.3.4 Product Benchmarking
18.3.5 Recent Developments, 2018-2021
18.4 Philips Respironics
18.4.1 Company Snapshot
18.4.2 Company Overview
18.4.3 Financial Analysis
18.4.3.1 Net Revenue, 2017-2021
18.4.3.2 Regional Revenue/Market Shares, 2021
18.4.3.3 Segmental Revenue/Market Shares, 2021
18.4.4 Product Benchmarking
18.5 Boehringer Ingelheim GmbH
18.5.1 Company Snapshot
18.5.2 Company Overview
18.5.3 Financial Analysis
18.5.3.1 Net Revenue, 2017-2021
18.5.3.2 Regional Revenue/Market Shares, 2021
18.5.3.3 Segmental Revenue/Market Shares, 2021
18.5.4 Product Benchmarking
18.5.5 Recent Developments, 2018-2021
18.6 3M Healthcare
18.6.1 Company Snapshot
18.6.2 Company Overview
18.6.3 Financial Analysis
18.6.3.1 Net Revenue, 2017-2021
10.2.1.1 Regional Revenue/Market Shares, 2021
18.6.3.2 Segmental Revenue/Market Shares, 2021
18.6.4 Product Benchmarking
18.6.5 Recent Developments, 2018-2021
18.7 AstraZeneca plc
18.7.1 Company Snapshot
18.7.2 Company Overview
18.7.3 Financial Analysis
18.7.3.1 Net Revenue, 2017-2021
18.7.3.2 Regional Revenue/Market Shares, 2021
18.7.3.3 Segmental Revenue/Market Shares, 2021
18.7.4 Product Benchmarking
18.7.5 Recent Developments, 2018-2021
18.8 Merck & Co., Inc.
18.8.1 Company Snapshot
18.8.2 Company Overview
18.8.3 Financial Analysis
18.8.3.1 Net Revenue, 2017-2021
18.8.3.2 Regional Revenue/Market Shares, 2021
18.8.3.3 Segmental Revenue/Market Shares, 2021
18.8.4 Product Benchmarking
18.9 Novartis AG
18.9.1 Company Snapshot
18.9.2 Company Overview
18.9.3 Financial Analysis
18.9.3.1 Net Revenue, 2017-2021
18.9.3.2 Regional Revenue/Market Shares, 2021
18.9.3.3 Segmental Revenue/Market Shares, 2021
18.9.4 Product Benchmarking
18.9.5 Recent Developments, 2018-2021
18.10 Omron Corporation
18.10.1 Company Snapshot
18.10.2 Company Overview
18.10.3 Financial Analysis
18.10.3.1 Net Revenue, 2017-2021
18.10.3.2 Regional Revenue/Market Shares, 2021
18.10.3.3 Segmental Revenue/Market Shares, 2021
18.10.4 Product Benchmarking
18.10.5 Recent Developments, 2018-2021
18.11 Sunovion Pharmaceuticals Inc.
18.11.1 Company Snapshot
18.11.2 Company Overview
18.11.3 Financial Analysis
18.11.3.1 Net Revenue, 2017-2021
18.11.3.2 Regional Revenue/Market Shares, 2021
18.11.4 Product Benchmarking
18.11.5 Recent Developments, 2018-2021
18.12 Teva Pharmaceuticals
18.12.1 Company Snapshot
18.12.2 Company Overview
18.12.3 Financial Analysis
18.12.3.1 Net Revenue, 2017-2021
18.12.3.2 Regional Revenue/Market Shares, 2021
18.12.4 Product Benchmarking
18.12.5 Recent Developments, 2018-2021
18.13 Cipla Limited
18.13.1 Company Snapshot
18.13.2 Company Overview
18.13.3 Financial Analysis
18.13.3.1 Net Revenue, 2017-2021
18.13.4 Product Benchmarking
18.13.5 Recent Developments, 2018-2021
18.14 Recipharm Ab.
18.14.1 Company Snapshot
18.14.2 Company Overview
18.14.3 Financial Analysis
18.14.3.1 Net Revenue, 2016-2020
18.14.3.2 Regional Revenue/Market Shares, 2021
18.14.4 Segmental Revenue/Market Shares, 2021
18.14.5 Product Benchmarking
18.14.6 Recent Developments, 2018-2021
18.15 Medisana GmbH.
18.15.1 Company Snapshot
18.15.2 Company Overview
18.15.3 Product Benchmarking
18.16 Graham Field Health Products
18.16.1 Company Snapshot
18.16.2 Company Overview
18.16.3 Product Benchmarking
18.17 AptarGroup, Inc.
18.17.1 Company Snapshot
18.17.2 Company Overview
18.17.3 Financial Analysis
18.17.3.1 Net Revenue, 2017-2021
18.17.3.2 Regional Revenue/Market Shares, 2021
18.17.4 Segmental Revenue/Market Shares, 2021
18.17.5 Product Benchmarking
18.17.6 Recent Developments, 2018-2021
19 Conclusion and Recommendations
19.1 Concluding Remarks from Visiongain
19.2 Recommendations for Market Players
19.3 Leading Regions and Fastest Growing Region (North America Region Accounted for the Largest Market Share)
ページTOPに戻る
Visiongain社の医薬・化学品分野での最新刊レポート
本レポートと同じKEY WORD(accessories)の最新刊レポート
よくあるご質問
Visiongain社はどのような調査会社ですか?
英国の調査会社ヴィジョンゲイン社(Visiongain)は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|